Posted on

TR Capital Positions Firm to Capture Tremendous Growth Opportunity in Southeast Asia with New Singapore Office

SINGAPORE, Sep 16, 2022 - (ACN Newswire via SEAPRWire.com) - TR Capital, the leading Asian secondary private equity firm, today announced the opening of its fifth office in the APAC region, and the firm's Southeast Asia Headquarters, in Singapore. Paul Robine, Founder and CEO of TR Capital, said, "We see huge potential in the secondary private equity market in Singapore, as well as the wider Southeast Asia ("SEA") region, making Singapore a strong new location for TR Capital, in addition to our offices in Greater China and India. This combined with favourable policies designed to cement Singapore's position as a financial hub, make it an obvious choice from which to create value for our investors."The Southeast Asia region presents significant opportunities for investors, with its fast-growing consumer trends, sought-after technology companies and lively start-up culture. The private equity market in Southeast Asia reached an all-time high of US$25 billion in deal value in 2021, more than double the 2020 figure(1) . Singapore led this growth in both the number of deals and their value, recording 104 deals worth a total of US$12.1 billion. In the coming years, SEA-focused private equity firms will look for exit opportunities to meet their liquidity needs. As a secondary investor, TR Capital will be well-positioned to capitalize on these market dynamics."At TR Capital, our strategy is centred around making investments in innovative and established leaders from the technology, consumer, and healthcare sectors. Our focus on secondaries comes at a critical time when many private equity firms are evaluating exiting assets, while institutional investors are also looking to rebalance their portfolios amidst an environment of highly volatile market conditions," continued Mr. Robine. "Given our active investment style, we have always placed importance on having local offices on the ground run by strong local teams. We are incredibly proud to be the only secondary private equity firm to have five offices in Asia ex-Japan. The new office in Singapore perfectly positions us to capture emerging opportunities in Southeast Asia, which will complement our investments in China and India." TR Capital is led by Founder and CEO Paul Robine, and by Managing Partners Colin Sau and Frederic Azemard, with flagship offices in Hong Kong and Singapore, and additional offices and local teams in Shanghai, Shenzhen and Mumbai. About TR Capital TR Capital is a leader in secondary private equity investments in the Asia-Pacific region. TR Capital focuses on providing liquidity solutions to owners of private equity assets through Secondary Direct (single asset) and Fund Restructuring (portfolio) transactions. The firm targets significant positions in established leaders in the Technology, Consumer and Healthcare sectors. TR Capital is an active investor and shareholder and works with its portfolio companies to optimize their business models and capital structures. TR Capital currently manages four funds with capital commitments of over US$1.2 billion. The firm's sophisticated investor base includes sovereign funds, pension funds, asset management firms, entrepreneurs, and family offices. Founded in 2007, TR Capital has subsequently closed 40 secondary investments and built a solid track record closing four funds since launch. TR Capital's 30 professionals are based in offices in Hong Kong, Singapore, Shanghai, Shenzhen and Mumbai. (1) 2022 annual Southeast Asia Private Equity report by Bain & Company For more information, please contact:Artemis AssociatesDiana Footitt, CEOM: +852 9183 0667E: diana.footitt@artemisassociates.com Claire Wong, Managing DirectorM: +65 8266 4213E: clairew.wong@artemisassociates.comBowen Chui, DirectorM: +852 9783 0643E: bowen.chui@artemisassociates.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Legend Capital: The Logic of Technology Investment Has Changed

HONG KONG, Sep 2, 2022 - (ACN Newswire via SEAPRWire.com) - Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022. In addition, Legend Capital's CRO portfolio company R&G Pharmastudies was successfully listed on the ChiNext of Shenzhen Stock Exchange on 2 August 2022, while on 5 August 2022, the innovative drug portfolio company MicuRx Pharmaceuticals went public on the STAR Market, becoming the 101st IPO and the 102nd IPO in Legend Capital's investment portfolio. In a recent interview, Richard Li, President of Legend Capital, revealed the history of Legend Capital in technology investment and proposed that the logic of technology investment has undergone important changes.Over 100 IPOs and 100 UnicornsLegend Capital pays more attention to the quality rather than the quantity of IPOs, but the 100th IPO remarks an important milestone for Legend Capital. Richard Li, President of Legend Capital, said in the interview: "What matters is not about the quantity of IPOs, but more about the repeated verification of the investment expertise of Legend Capital team, who has long been rooted in technology investment.From Lunit to R&G Pharmastudies and MicuRx Pharmaceuticals, these IPO achievements at home and abroad are in line with Legend Capital's development: starting from the USD fund and growing stronger with the RMB fund. Among its peers, Legend Capital stands out with its distinctive feature - it is well-versed in the system of USD funds, but is also rooted in China and inherently adept at a local investment with the RMB fund.Looking back at Legend Capital's development history, we can see a microcosm of the changes in China's technology investment. In Richard Li's memory, since the company's investment in iFLYTEK in 2001, Legend Capital has been systematically investing in companies that are in the early stages of technological innovation, and many of them have become industry leaders such as iFLYTEK, Spreadtrum, CATL, WuXi AppTec, Pharmaron, Wuxi Lead Intelligent and CNGR Advanced Material, etc., tapping into core sectors of new energy, semiconductor, life science, new materials and so on. So far, among Legend Capital's invested companies, there are over 100 unicorn companies with a valuation of over USD1 billion, creating a huge and systematic technology investment footprint.With over two decades of expertise, Legend Capital has cultivated a profound understanding of the technology and innovation drives of China, accumulated rich resources around industries, and built a powerful portfolio ecosystem. Legend Capital helps overseas enterprises expand business in the Chinese market and promotes the global expansion of enterprises by bridging key resources in China such as R&D and supply chain.On the other hand, by leveraging its "China Insights", Legend Capital also helps portfolio companies and entrepreneurs in China to "go global" and achieve strategic objectives across the border by integrating overseas resources and opportunities, helping portfolio companies to respond to complex changes in the global industry landscape and meanwhile generating new investment opportunities.The Significance of 100 IPOsLooking back at the 100 IPOs, they are remarkably diverse while at the same time representing a consistent theme. Regarding the breakdown of listing location, 31 of our portfolio companies were successfully listed on Shenzhen Stock Exchange, 20 on Shanghai Stock Exchange, 22 on Hong Kong Stock Exchange, 1 on Taiwan Stock Exchange, 4 on New York Stock Exchange, 16 on Nasdaq, 5 on Korea Stock Exchange, 1 on Japan Exchange Group. With the majority listed on A-share markets, Legend Capital has extensive exit experience in multiple capital markets, which is relatively rare in investment institutions in China.From the market value (in RMB), there is 1 company with a market value of trillions - CATL; 10 companies with a market value of 100 billion, such as iFLYTEK, Pharmaron, WuXi AppTec, WuXi Biologics, Wuxi Lead Intelligent, Shanghai Putailai New Energy, CNGR Advanced Material, and JD Logistics; 15 companies with a market value of more than 50 billion, and 43 companies with a market value of more than 10 billion; and 25 of them are "little giants" companies with Specialization, Refinement, Differentiation & Innovation features. Legend Capital is active behind the rise of many Chinese technology companies.Richard Li summarized several characteristics regarding Legend Capital's 100 IPOs: First, it covers multiple sectors. The second is balance, which is also one of the deep impressions that Legend Capital has left on the public - internationalization practices in RMB funds and extremely strong localization capabilities in USD funds. Third, investment in technological innovation projects is the main focus, and investment in pure business model-innovation projects is relatively small. In addition, Legend Capital acts as the lead investor in most of its portfolio with a relatively large shareholding ratio, thus having board seats and could exert a certain influence on the operation of portfolio companies.Patience capital in industrial chain investmentFounded in 2001, Legend Capital has experienced 20 years of technology iteration and innovation in China. "The founding team of Legend Capital all came from industrial rather than financial backgrounds, which determines the industrial and technology innovation genes of Legend Capital," Richard Li recalled. In China, Legend Capital is a pioneer in making technology investments using USD funds, much earlier than many of today's first-tier USD funds. Since 2015, Legend Capital has changed from a single fund investment business team to a unified platform to manage the operation of multiple funds, including long-term PE funds, TMT specialized funds, health care specialized funds, etc., to compose a more synergistic team.This synergy effect is reflected in Legend Capital's investment across different platforms and funds. With regard to its investment in the semiconductor industry, Legend Capital has systematic research on semiconductor companies and makes selective investments, with different funds investing in different types of targets. For example, Legend Capital invests in some enterprises that integrate resources and iterate products under a mature technology framework. Once successful, they will create a huge market of the replacement of the current framework, and even the first round of financing for these enterprises would reach billions of dollars. In the long run, they will grow into companies with a market value of hundreds of billions of dollars. Under such circumstances, Legend Capital will make a large proportion of investment through mature PE funds.However, the entire semiconductor industry is still in the early stage of development currently, and the latest semiconductor technology represents a new design concept and architecture, as well as a trend in cutting-edge technology. At this stage, many start-up technology companies need our support in the form of early-stage fund investment that accompanies their development in the long run. This will in turn contribute to the diversification, synergy and expansion of Legend Capital's investment tools and targets.The investment in the lithium battery industry, on the other hand, reflects the industry chain investment theme that is rooted in the industry background of the Legend Capital team. Benefiting from the long-term in-depth layout in the industrial mapping and the precise control of investment timing, Legend Capital has realized a number of landmark investments in the new energy field. Among them, projects such as Lead Intelligent, CATL, PUTAILAI, CNGR, Hymson have created huge returns for Legend Capital.Based on the prediction of the scale and trend of the downstream industry, Legend Capital has also systematically invested in assisted and autonomous driving along the direction of intelligent and unmanned new energy vehicles, as well as related sensor, radar, chip, and other projects in similar niches. Typical cases include Pony.ai, Zongmu Technology, MUNIU Tech, Black Sesame Technologies, etc.Richard Li said frankly: "Distinct from the internet sector, hard technology companies have a relatively long incubation period. Technology verification and productization need to be completed in the early stage, then put into the market, and then gradually scale up. The industry has large development potential and the enterprises have strong profitability. However, the market environment is complex, so it is hard for 'one winner to take all', and it is unrealistic to rely on first-mover advantage to achieve home runs. Therefore, investment institutions need to grasp the inflection point of the industry, such as when the effectiveness of the technology could be verified and when the product develops rapidly, which tests investors' judgment on timing.Richard Li summed it up in this way: To invest in science and technology, it is necessary to have an industrial mindset, sort out the industrial map, and then invest according to the timing of different stages and nodes of the industry. After that, we need to wait, and time will show us the answer. Investment institutions should have the patience and determination to accompany enterprises for a long time.The Logic of Technology Investment Has Changed Looking back on 20 years of experience in China's Venture Capital, Richard Li exclaimed that the industry is undergoing great changes today. "It's a systemic change including funding sources, investment directions and exit channels." He believes that these years are a critical turning point for the industry. Investment institutions need to make targeted adjustments to accommodate the new environment.In the past, the fundraising and exit of USD funds were both structured abroad, which led to most of the funds not actually investing in China. "To some extent, it is equivalent to going public in the United States with financial statements submitted from companies in China, and then selling shares in the United States market to exit." US dollar investors must now face up to the fact that the old game is over.Richard Li bluntly remarked that when USD funds began to shift investment focus from business model innovation to hard technology, in addition to the changes in target investment fields, the fundamental difference between the historic "two-end abroad" to invest in Chinese Concept Stocks and the new reality of China-rooted model of "investing onshore in China" put forth significant requirements for the localization of investment institutions, which requires long-term accumulation of resource networks and support from mid to back office.Besides, to be successful in using USD funds to invest in hard technologies in China with a focus on local listings and exits, it is very important to manage a complementary large-scale RMB fund as the cooperation between the two derives unique differentiation. Otherwise, we can only invest in individual "Cusp" projects opportunistically, rather than systematically investing in a long-term sustainable manner.This is also the challenge and opportunity that Legend Capital has always emphasized. Our latest plan focuses on technology investment, while paying attention to domestic A-share exit channels, we also take into account the exit channels for overseas investment projects in overseas capital markets, including Hong Kong stocks, US stocks, and capital markets such as South Korea and Japan. "Actually, these plans are things that we started doing a few years ago. If you just start to do these things today, I think it's too late." Said Richard Li.About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea. It currently manages USD and RMB funds of over US$10 billion in commitments and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies through solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Leading VC Firm, Black3Lab Capital Announces Investment in Ripe Web 3.0 Sectors

New York, NY, September 02, 2022 – (SEAPRWire) – Black3Lab Capital, a venture capital firm built to empower web 3.0 companies with potential for global mass adoption, has announced investments in ripe web 3.0 sectors. Black3Lab’s proposed $50 to $100 million fund will focus on building a genuinely feasible economy of web 3.0-fueled products and services for the global populace. In addition to investing in potentially productive web 3.0 sectors, Black3Lab will undertake the enterprise adoption of social media, gaming, and NFTs. At a recently concluded launch ceremony, co-founder of Black3Lab, Alex Chong, announced that the putative investment fund is in partnership with three famous partners. The Black3Lab fund will focus primarily on enriching projects with the potential to accelerate global adoption. “We are hyper-focused on web 3.0 companies with the suitable DNA to integrate with existing conglomerates with millions of customers for Black3Lab portfolio companies to tap. Ultimately, mass user adoption will allow web 3.0 platforms and projects to achieve explosive growth and sustainable revenue generation capabilities,” Alex Chong reveals. Unlike web 2.0, which gave rise to internet giants like Google, Apple, Facebook, etc., web 3.0 promotes user-centric ownership, harmonizing perfectly with human incentives. Speaking about the current web 2.0 internet phase and the rise of centralized tech giants, the co-founder of Black3Lab reiterated Alex Chong’s claims of web 3.0’s potential to deliver at least ten times the market opportunities of the former. “User-centric networks deliver significantly higher and more explosive growth than their centralized competitors. At the core, you can always find more favorable terms for users. Web 2.0 gave birth to a US$10 trillion market, and now web 3.0 has the potential to deliver ten times the market opportunities,” Candy states. The Black3Lab fund will incorporate a dynamic trading strategy that delivers consistent returns of over 30% to investors. Black3Lab Partners Per Alex Chong’s announcement at the launch ceremony held at the Peninsula Hotel, Hong Kong, on 18th August 2022, Black3Lab has partnered with notable media veterans like Bob. Bob led the global collaboration team of some of the biggest media tech companies. He also led Strategies and Partnerships at Forkast—a web 3.0 media ecosystem. Bob recapitulates Candy’s idea of user-centric ownership as the key to driving mass adoption in the emerging web 3.0 space. “Black3Lab Capital is notably unique: We exist not just out of the goal for strong financial returns but to foster the mass adoption of web 3.0 solutions. We believe user-centric ownership will be the key to unleashing the next-generation internet,” Bob says. About Black3Lab Capital Black3Lab Capital is a VC firm founded in Hong Kong. Black3Lab aims to empower web 3.0 companies with maximum potential for accelerated mass success, offering high returns to investors. The team comprises renowned enterprise founders, tech developers, VCs, media executives, and F&B entrepreneurs keen on introducing a more equitable, rewarding, and innovative internet economy. Social Contact Instagram: https://www.instagram.com/black3lab/ Media Contact Brand: Black3Lab Capital Contact: Alex Chong, Co-founder & Partner Email: info@black3lab.com Website: https://www.black3lab.com/ PR provider:  https://finpr.agency SOURCE: Black3Lab Capital The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)

Read More
Posted on

Glenn Haifer 博士和 Ampersand Capital Partners 收购澳大利亚生物制品 CDMO Luina Bio，更名为 AcuraBio

BRISBANE, AUS, Aug 31, 2022 - (亚太商讯 via SEAPRWire.com) - AcuraBio（前身为 Luina Bio）是澳大利亚领先的生物制药 CDMO，已被生物技术投资者 Glenn Haifer 博士和全球医疗保健私募股权公司 Ampersand Capital Partners 收购。AcuraBio 拥有二十多年的经验，是一家专注于全球的组织，为生物技术、制药和动物健康行业的客户提供创新疗法。 AcuraBio 为处于新兴疗法前沿的客户提供重组蛋白和疫苗以及复杂的活体生物治疗产品。公司的品牌重塑标志着 AcuraBio 进入了一个创新的新增长阶段。作为交易的一部分，Haifer 博士和 Ampersand 将为公司带来大量投资，重点是扩大组织以更好地为客户服务。为了推动进一步的增长，AcuraBio 正计划提高生产设施的产能，并正在积极评估向新服务产品和技术能力的扩展。Haifer 博士为 AcuraBio 带来了丰富的经验，作为前公司董事长和投资者，在 Agilex Biolabs 和 Avance Clinical 等澳大利亚生物技术的成功背后。 “我们很高兴能够重塑一家拥有如此深厚科学经验的公司，”海弗博士说。 “凭借我们深厚的专业知识和对进一步投资的承诺，AcuraBio 将成为亚太地区的领导者，为国际生物制药客户带来我们将为平台带来的技术、科学卓越和创新所吸引。随着我们将 AcuraBio 提升到一个新的水平，我很高兴能够利用 Ampersand 的行业专业知识。”Ampersand 总部位于美国，管理超过 30 亿美元的资产，专注于医疗保健领域的增长型投资。 Ampersand 此前曾与 Brammer Bio、ArrantaBio、Vibalogics 和 Genezen 等领先的 CDMO 合作，该公司是新兴治疗 CDMO 行业经验丰富的投资者。 Ampersand 的普通合伙人 David Anderson 表示：“AcuraBio 在澳大利亚的战略定位是支持国际生物制药药物开发。澳大利亚在临床和科学卓越方面享有盛誉，这是像 AcuraBio 这样的公司取得成功的基础。我们非常高兴与 Haifer 博士合作，他是一位久经考验的生物技术投资者和增长战略家，真正专注于以客户为中心的服务创新。”关于AcuraBioAcuraBio Pty Ltd 是澳大利亚最有经验的生物制药 CDMO 之一，在过去 20 年中为国内外客户提供值得信赖的、以客户为中心的服务。 AcuraBio 为世界各地的生物制药公司提供重要的质量、成本和知识产权保证。世界一流的研究人员和成熟的设施、精简的监管框架、慷慨的税收优惠和政府资助使澳大利亚成为生物技术研究的主要地点。 AcuraBio 拥有以下经营许可证：TGA（澳大利亚 FDA 等效）许可证，用于从生物和合成来源制造人类治疗性 API，APVMA（TGA 兽医等效）许可证，用于制造无菌免疫生物产品，OGTR 许可证，用于生产基因产品改性生物体，以及用于进口和使用生物材料的 DAF 设施许可证。有关 AcuraBio 的更多信息，请访问 www.acurabio.com。关于Ampersand 资本合伙人Ampersand 成立于 1988 年，是一家中型市场私募股权公司，管理超过 30 亿美元的资产，致力于医疗保健领域的增长型投资。 Ampersand 在波士顿和阿姆斯特丹设有办事处，利用其独特的私募股权和运营经验相结合，与投资组合公司管理团队一起寻求创造价值并推动强劲的长期业绩。 Ampersand 帮助在公司的每个核心医疗保健领域建立了众多市场领先的公司。有关 & 的更多信息，请访问 www.ampersandcapital.com。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

Read More
Posted on

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

BRISBANE, AUS, Aug 30, 2022 - (ACN Newswire via SEAPRWire.com) - AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm.With more than two decades of experience, AcuraBio is a globally focussed organization bringing innovative therapeutics to market for customers in the biotech, pharmaceutical, and animal health industries. AcuraBio provides recombinant proteins and vaccines, and complex live biotherapeutic products to customers on the leading edge in emerging therapeutics. The rebranding of the company signifies an innovative new growth phase for AcuraBio. As part of the transaction, Dr. Haifer and Ampersand are bringing significant investment to the company, with a focus on expanding the organization to better serve customers. To fuel additional growth, AcuraBio is planning to increase production facility capacity, and is actively evaluating expansion into new service offerings and technological capabilities. Dr. Haifer brings a wealth of experience to AcuraBio, as the former company Chairman and investor behind Australian biotech successes such as Agilex Biolabs and Avance Clinical. "We are very excited to be reinventing a company with such deep scientific experience," said Dr. Haifer. "With our deep expertise and commitment to further investment, AcuraBio will be a leader in the APAC region for international biopharma clients attracted by the technology, scientific excellence, and innovation we will bring to the platform. I am excited to leverage Ampersand's industry expertise as we take AcuraBio to the next level." Based in the US and with more than $3 billion of assets under management, Ampersand is exclusively focused on growth-oriented investments in the healthcare sector. Ampersand has previously partnered with leading CDMOs such as Brammer Bio, ArrantaBio, Vibalogics, and Genezen, and the firm is a highly experienced investor in the emerging therapeutics CDMO industry. David Anderson, General Partner at Ampersand, said "AcuraBio is strategically positioned in Australia to support international biopharma drug development. Australia has a strong reputation for clinical and scientific excellence which is the foundation to success for a company like AcuraBio. We are extremely pleased to be working with Dr. Haifer, who is a proven biotech investor and growth strategist with a real focus on client-centric service innovations."About AcuraBioAcuraBio Pty Ltd is one of Australia's most experienced biopharmaceutical CDMOs, offering trusted, client-focused services to both domestic and international clients for the past 20 years. AcuraBio offers significant quality, cost, and IP assurances for biopharma companies around the world. World-class researchers and proven facilities, a streamlined regulatory framework, generous tax incentives, and government funding make Australia a prime location for biotech research. AcuraBio has the following operating licenses: TGA (Australian FDA equivalent) license for the manufacture of human therapeutic APIs from biological and synthetic sources, APVMA (veterinary equivalent of the TGA) license for manufacture of sterile immunobiological products, OGTR license to produce products from genetically modified organisms, and a DAF facility license for import and use of biologic materials. Additional information about AcuraBio is available at www.acurabio.com.About Ampersand Capital PartnersFounded in 1988, Ampersand is a middle market private equity firm with more than $3 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience in seeking to build value and drive strong long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. Additional information about Ampersand is available at www.ampersandcapital.com. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY

HONG KONG, Aug 19, 2022 - (ACN Newswire via SEAPRWire.com) - Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. The proceeds from this round of financing will be used to accelerate the product R&D, market expansion, and data-driven precision medicine development and help APTBIO continue to develop in mass spectrometry multi-omics applications, innovative drug development, and preclinical research, making a forward-looking layout for the construction of precision medicine services driven by big data and AI. Founded in July 2004, APTBIO is one of the earliest biotechnology companies engaged in proteomics technical services and biopharmaceutical research and analysis services in China and participated in establishing China's biological mass spectrometry applications from scratch. With headquarter in Shanghai, APTBIO has a nationwide sales network and it has built innovative technology centers, data centers, and clinical testing centers in Shanghai, Yiwu, and Taizhou, with a total area of more than 20,000 square meters. Centering on the construction of the life and health industry chain, APTBIO has established four major technology platforms through technical cooperation and its innovation capabilities: a large-scale multi-omics platform, biopharmaceutical preclinical research and small-scale production platform, mass spectrometry clinical detection and companion diagnostic platform, and an AI and big data platform. By laying out the three business segments of technology services, biomedical CRO services, and mass spectrometry clinical testing services, APTBIO has built a business map around multi-omics and big data to provide a precise platform for the perfect transformation from basic research to clinical application. Ms. CHEN Wei, the founder of APTBIO, said: "I would like to take this opportunity to extend my sincere gratitude to our investors. This round of capital input fully validates the rapid development and future potential of APTBIO in mass spectrometry multi-omics-based precision medicine and pre-clinical CRO for drug R&D. With the completion of the new round of financing, we will further promote the local and global market layout, innovative biomedical business interaction, and data-driven precision medicine capacity, to contribute to the human health industry."Hank ZHOU, the co-chief investment officer of Legend Capital, said: "APTBIO is a leading enterprise in multi-omics R&D services in China, covering a wide range of areas such as technology services, biomedical R&D, precision medicine, and it provides integrated services for the transformation from basic research to clinical application. APTBIO has laid out cutting-edge technologies in various fields in advance, such as proteomics and metabolomics, and its high-quality R&D technical team has achieved breakthroughs in multiple research fields. We are honored to participate in the future development of APTBIO and are willing to work together with the company to establish APTBIO as a leader in the multi-omics R&D industry."About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea. It currently manages USD and RMB funds of over US$10 billion in commitments and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies through solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative. For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Elite Partners continues acquisition spree with the purchase of a warehouse in Poland

Singapore, Aug 16, 2022 - (ACN Newswire via SEAPRWire.com) - Elite Partners Capital has completed an off-market acquisition of a warehouse in Radomsko, Poland for close to EUR30 million. This marks the firm's third purchase within a span of six weeks, after announcing acquisitions in UK and Netherlands.The asset is well-located in Central Poland, being in the immediate vicinity of the A1 motorway, national roads DK 42 and DK 91, as well as key railway junctions. It is the first facility within "LOOGIC Park Radomsko" logistics park which will eventually house 11 warehouse halls totalling 380,000 sqm over 80 hectares of land. The warehouse provides a total usable area of approximately 54,000 sqm and achieved an 'Excellent' BREEAM certification. It was constructed by FB ANTCZAK, Polish general contractor, as a Built-to-Suit facility for JYSK, a big box retailer of household goods. JYSK is the largest Danish retailer operating internationally with over 3,000 stores in 48 countries globally. The warehouse is used primarily for high-volume storage and is strategically located near the main JYSK Distribution Center. This allows JYSK to distribute goods efficiently and lower transport costs, ultimately having a positive effect on the environment through reduction of CO2 emissions. This is the first Polish acquisition for the second series of EPC's Logistic Funds. "Following our recent string of successful investments, we are pleased to announce the acquisition of the Polish warehouse facility that is fully let to JYSK," said Mr Victor Song, CEO of Elite Partners Capital. "We are no stranger to the Polish market and have forged trusted relationships on the ground. Because of this, we are able to efficiently source for select opportunities that provide attractive returns even in today's volatile market."Elite Logistics Fund II continues to focus on building a portfolio of high-quality logistics warehouse or infrastructure across Europe and the UK.For this transaction, DLA Piper (Legal) advised Elite Partners Capital and AXI IMMO Group acted for the Vendor.About Elite Partners CapitalIncorporated in 2017, Elite Partners Capital is a Singapore-based licensed fund manager. The Elite Logistics Fund series has a Pan-European strategy focusing on prime logistics assets in the high-growth and defensive sectors. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

HONG KONG, Aug 15, 2022 - (ACN Newswire via SEAPRWire.com) - On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. R&G Pharmastudies publicly issued 15,000,000 shares at a price of RMB78.88 per share, and the total amount of funds raised is expected to be RMB1.18 billion.R&G PharmaStudies is a large-scale professional clinical trial outsourcing service supplier in China. It has established a complete set of pharmaceutical R&D outsourcing service systems covering the whole chain of clinical trials. R&G PharmaStudies provides integrated services throughout the entire process of clinical trials with its comprehensive drug R&D service system; the main services offered by the company cover clinical trial operation services, clinical trial site management services, biological sample testing services, data management, and statistical analysis services, clinical trial consulting services, clinical pharmacology services, etc. R&G PharmaStudies is committed to providing high-quality and efficient clinical research services in line with international standards. With a broad and high-quality customer base, it has provided professional services for about 750 Chinese and foreign pharmaceutical companies.Legend Capital invested in the Series A round of R&G PharmaStudies in the second half of 2017 and has kept on supporting the development of R&G PharmaStudies. Jafar Wang, the Co-Chief Investment Officer of Legend Capital, said, "Congratulations on the successful listing of R&G PharmaStudies! R&G PharmaStudies is a veteran of China's pharmaceutical clinical CRO industry and has long provided full-chain clinical CRO services for Chinese and foreign innovative pharmaceutical enterprises. The successful listing will be the starting point of the new long run of R&G PharmaStudies; with its global vision, well-known expert team, and high-quality service system, we are optimistic about the long-term development potential of R&G PharmaStudies, and look forward to the continuous growth of the company." Legend Capital has a systematic layout in CRO/CDMO. In addition to R&G PharmaStudies, Legend Capital has invested in plenty of other new-drug R&D CRO/CDMO companies, such as WuXi Apptec, WuXi Biologics, Pharmaron, Bellen, ClinChoice, SAFE Pharmaceutical, dMed Biopharmaceutical, XiHua Scientific, BirdoTech, Intellective Biologics, Biortus, and Simoon Record.About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea. It currently manages USD and RMB funds of over US$10 billion in commitments and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies through solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative. For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully

HONG KONG, Aug 9, 2022 - (ACN Newswire via SEAPRWire.com) - On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market. MicuRx Pharmaceuticals issued 130,000,000 shares this time, accounting for 19.84% of the total share capital after the issuance. The total amount of funds raised is expected to be about RMB 960 million at the issue price of 8.16 yuan per share. MicuRx Pharmaceuticals is an innovative drug company focusing on novel therapeutics for infectious diseases. With global independent intellectual property and competitiveness, MicuRx Pharmaceuticals is committed to the discovery, development, and commercialization of innovative drugs for unmet medical needs. The main products from MicuRx Pharmaceuticals include Contezolid, MRX-4, and MRX-8. Since the company's establishment, MicuRx Pharmaceuticals has adhered to the principle of "Better therapy through superior medicine", focusing on the increasingly severe problem of bacterial resistance worldwide. With the core competitiveness of solving clinical problems and differentiated innovation, MicuRx Pharmaceuticals aims to provide more effective and safer therapeutic options for patients suffering from the most common and severe drug-resistant bacterial infections. MicuRx Pharmaceuticals has an international core R&D team and has established R&D centers in China and the US. The company's R&D team has rich experience in international innovative drug development and management, and it has led or participated in developing a number of marketed anti-infective new drugs. Legend Capital invested in MicuRx Pharmaceuticals in 2020 and has long supported the company's development. "Congratulations to MicuRx Pharmaceuticals. The successful listing represents the recognition of MicuRx Pharmaceuticals' innovative R&D in the field of multi-drug-resistant bacterial infection and its globally competitive innovative drug. Legend Capital and the MicuRx team have established a deep friendship, and Legend Capital is honored to participate in the MicuRx business led by Dr. Zhengyu YUAN, the founder of MicuRx Pharmaceuticals. Dr. YUAN is a very tenacious and spiritual entrepreneur who dares to take risks, filling the Chinese market gap in the scarce field of multi-drug-resistant bacterial infection. With the consolidation of the company's leading edge and position, Dr. YUAN has not only built an international team and an innovative global enterprise but also made positive contributions to the development of human health." Said Legend Capital.Legend Capital has long paid close attention to investment in significant themes in the field of life sciences. In addition to MicuRx Pharmaceutical, Legend Capital has also made investments in plenty of other outstanding companies, many of which were listed on A-shares and H-shares, such as Pharmaron (300759.SZ) (03759.HK), Kingmed Diagnostics (603882.SH), Wuxi Apptec (603259.SH) (02359.HK), WuXi Biologics (02269.HK), Recbio (02179.HK), Innovent Biologics (01801.HK), Berry Genomics (000710.SZ), Harbour BioMed (02142.HK), New Horizon Health (06606.HK), and Chemclin Diagnostics (688468.SH).About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea. It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies through solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative. For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B

HONG KONG, Aug 8, 2022 - (ACN Newswire via SEAPRWire.com) - Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B round of fundraising with over RMB 300 million, which is backed by Legend Capital. This round of fundraising will be mainly used to improve the development of the echelon utilized product series, the construction of new energy retired lithium battery recycling capacity, and the expansion of new lithium battery wet recycling technology.Founded in 2017, Ruicycle is a national high-tech enterprise dedicated to "Making New Energy a Truly Green Energy", deeply engaging in the field of recycling and comprehensive utilization of retired power batteries. It is committed to pursuing the concept of green and low-carbon development. Directing at the end of the new energy industry, Ruicycle has built an industrial ecological closed loop of large-scale automatic safe crushing, zero-pollution treatment, and high-efficiency recycling of lithium batteries based on the core technologies of lithium battery echelon utilization, material regeneration, and new material regeneration. Meanwhile, centering on the national carbon peaking and carbon neutrality policies, Ruicycle has achieved the traceability of carbon footprint and the quantification of carbon reduction, continuously making contributions to low-carbon development for the new energy industrial chain.In 2020, Ruicycle was granted the qualifications of "Echelon Utilization White List" and "Recycling Utilization White List", becoming the fully licensed enterprise in the lithium battery recycling industry. Ruicycles revenue exceeded RMB 1 billion with a CAGR of over 100% in 2021. Now it has been recognized as the first echelon enterprise in China's power battery recycling and comprehensive utilization industry.Ruicycle is the world-first company devoting intelligent management of temperature-sensing cameras to the retired battery storage field. It has established industrial bases for echelon utilization and recycling in Huizhou, Jiangmen, and Ganzhou, respectively, achieving a recycling capacity of 150,000 tons per year of retired power batteries. At the same time, Ruicycle has also been cooperating with Legend Capital's portfolio company Milkyway, a leading dangerous chemicals logistics enterprise, to build a global leading ESG recycling system.CHEN Zhipeng, the founder of Ruicycle, said: "We are a relatively young team. In keeping with the trend of the new energy era, we are eager to learn more from industry predecessors to root in the physical manufacturing industry more deeply. At the same time, we look forward to having more aspiring youngsters join us to create an efficient organization and together make contributions to the globalization of new energy industrialization experience.Legend Capital's investments in the carbon-neutral field focus on energy decarbonization, vehicle electrification/intelligence, synthetic biology, etc. Energy decarbonization includes photovoltaic, wind power, and smart grid; vehicle electrification/intelligence includes lithium battery vehicles, hydrogen fuel cell vehicles, battery recycling and others.Legend Capital has long been optimistic about investment opportunities in the new energy vehicle industry chain and has invested in a number of automation equipment, lithium batteries, and materials companies, many of which went public successfully, such as Wuxi Lead Intelligent Equipment (300450.SZ), CNGR Advanced Material (300919.SZ), Shanghai Putailai New Energy Technology (603659.SH), Shenzhen Hymson Laser Intelligent Equipments (688559.SH), Shenzhen Colibri Technologies (002957.SZ). At the same time, Legend Capital is also one of the early investors of CATL (300750.SZ).About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea. It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative. For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital ( https://www.linkedin.com/company/legend-capital ). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

TITAN CAPITAL MARKETS Introduces ‘Titan Ecosystem’ – Bridging the Market Gap between Academia and Forex Trading

CANBERRA, AUSTRALIA, July 28, 2022 – (SEAPRWire) – Recently, TITAN CAPITAL MARKETS introduces its “Titan Ecosystem”, which will Bridge the market gap between academia and forex trading. Foreign Exchange is the largest financial market in the world. According to Bank for International Settlements (BIS), the daily volume of the international foreign exchange market is about 6.6 trillion dollars. Foreign exchange trading is derived from the demand for international trade and currency exchanges. The market’s main participants include banks, industries with international trade needs, investors, and anyone who needs foreign exchange. There are a vast number of people investing in the foreign exchange market. However, with the features of large scale and high liquidity, more than 90% of novice investors will face investment failure and will be forced to exit the market. If one knows how to prepare countermeasures in advance, even a novice investor can boost the chances of making profits! Established in Australia, TITAN CAPITAL MARKETS PTY LTD is an integrated educational, financial group that holds both Australian Financial Services License (AFSL) and Money Services Business (MSB) License, and it is governed by ASIC (The Australian Securities and Investments Commission) and FINTRAC (Financial Transactions and Reports Analysis Centre of Canada.) Through many online and offline financial training courses and systematic social trading training programs, TITAN CAPITAL MARKETS helps members improve their financial mindset and quip them with forex trading skills. Furthermore, TITAN CAPITAL MARKETS has built up two professional trading teams with a combined experience of over 100 years – The Firefox Trading Team, led by Head Trader Anthony Jefferson and specializing in R-Breaker, scalping, and swing trading strategies, as well as the Wise Wings Trading Team, led by Head Trader Emmanuel Peterson, that specializes in diverse grid trading strategies. Members can conduct copy trading using any of the two teams or using TITAN’s superior Artificial Intelligence Arbitrage System and earn a sustainable income, create their financial ecosystem, and achieve their financial goals. To connect the forex trading strategies and experiences between each member and master traders, TITAN CAPITAL MARKETS has built the “Titan Wealth Ecosystem” with the aim of knowledge sharing and mutual value creation. Each trader can share their successful experiences in Forex trading in the Titan community, and they can even access the top trading strategies used by skilled master traders, allowing novice investors to master forex trading skills quickly and easily tap into the 6.6 trillion forex market. In addition, to provide a safer and more secure trading environment, TITAN CAPITAL MARKETS has partnered with the authoritative forex broker and I.B. query platform, WikiFX, and participated in its EPC(Eye Protection Centre) program at the highest legal aid A level to protect the interests of its users. TITAN CAPITAL MARKETS offers its members a guaranteed financial contract with principal protection and a maximum of $3,000 in compensation protection, ensuring the security of each member’s transactions. This move is well-appraised by its members. “Buy on limit down and sell on limit up” is a common saying that all investors should be familiar with, but it’s not that easy when it comes to Forex trading. With the ” Titan Wealth Ecosystem ” created by TITAN CAPITAL MARKETS and the use of a top-notch Artificial Intelligence Arbitrage System, not only can investors refer to master traders’ practical trading strategies and easily complete each foreign exchange transaction, but they can also continue to learn rich financial knowledge, grasp the latest information on the foreign exchange rate, and eventually create their own Forex trading success formula to outperform the foreign exchange market. ABOUT TITAN CAPITAL MARKETS TITAN CAPITAL MARKETS is an integrated educational financial group regulated by The Australian Securities and Investments Commission (ASIC ) and holds both the Australian Financial Services Licence (AFSL) and Money Services Business (MSB) License. Media Contact Brand: TITAN CAPITAL MARKETS Contact: Media team Email: info@titancapitalmarkets.com Website: https://titancapitalmarkets.com/ SOURCE: TITAN CAPITAL MARKETS The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)

Read More
Posted on

TITAN CAPITAL MARKETS Announces the Launch of Its EPC Program to Protect the Interests of Users

TITAN CAPITAL MARKETS CEO: The synergy of theoretical and practical Implications in forex trading CANBERRA, AUSTRALIA, July 28, 2022 – (SEAPRWire) – Howard Yan, the CEO of TITAN CAPITAL MARKETS, is proud to announce its EPC program, which will protect the interests of their users. Founded in Australia, TITAN CAPITAL MARKETS is a well-known integrated educational, financial group that holds both Australian Financial Services License (AFSL) and Money Services Business (MSB) License, and it is regulated by ASIC (The Australian Securities and Investments Commission) and FINTRAC (Financial Transactions and Reports Analysis Centre of Canada.) It boosts the wealth mindsets of its members and equips them with forex trading skills through substantial online and offline financial education courses combined with a systematic social trading program. At the 2022 Berkshire Hathaway annual shareholders meeting, Warren Buffett repeated his long-held advice that the best investment is anything that develops yourself. You don’t have to worry about inflation because the most vital protection against inflation is sharpening your skills. Whatever abilities you have can’t be taken away from you, and devolving your financial quotient can be the key to success in your life. With the development of the global financial industry, there is an increasing number of professional education institutions and knowledge-sharing platforms that focus on financial education. The Titan Wealth Community, established by TITAN CAPITAL MARKETS, has successfully brought a new wave to the economic and financial education industries by integrating the theoretical and practical aspects of financial education. TITAN CAPITAL MARKETS provides a robust trading platform that allows members to reap benefits by conducting transactions through the Titan Wealth Community with the top-notch Artificial Intelligence Arbitrage System. Furthermore, TITAN CAPITAL MARKETS has built two professional trading teams with a combined experience of over 100 years—The Firefox Trading Team, led by Head Trader Emmanuel Peterson and specializing in R-Breaker, scalping, and swing trading strategies, as well as the Wise Wings Trading Team, led by Head Trader Anthony Jefferson, and specializing in a diverse grid trading strategies. Members can conduct copy trading using any of the two teams to earn a sustainable income, create their financial ecosystem, and achieve their financial goals in life. To provide a safer and more secure trading environment, TITAN CAPITAL MARKETS has partnered with the authoritative forex broker and I.B. query platform, WikiFX, and participated in its EPC(Eye Protection Centre) program at the highest legal aid A level to protect the interests of its users. TITAN CAPITAL MARKETS offers its members a guaranteed financial contract with principal protection and a maximum of $3,000 in compensation protection, ensuring the security of each member’s transactions. This move is well-appraised by its members. Mr. Howard Yan also mentioned that the financial quotient, also known as F.Q., has two aspects. One is the ability to create wealth and understand the laws of wealth building, and the other is the ability to harness wealth. However, the common problem with financial education is a gap between knowledge and practical application. The advantage of Titan Wealth Community is that it helps members create a positive financial mindset and reduce misconceptions about financial ability. Titan Wealth Community connects the trading experiences between all members and skilled master traders. It helps novice traders outperform the market and build a sustainable income by applying the top trading strategies shared by other traders. The importance of financial education is gradually increasing. With the gradual establishment of a standardized system in the market, institutions with low professional ability will fall behind the market. We believe that advanced platforms such as the Titan Wealth Community will lead the industry and usher in a new epoch in the field of financial education. ABOUT TITAN CAPITAL MARKETS TITAN CAPITAL MARKETS is an integrated educational financial group regulated by The Australian Securities and Investments Commission (ASIC ) and holds both the Australian Financial Services Licence (AFSL) and Money Services Business (MSB) License. Media Contact Brand: TITAN CAPITAL MARKETS Contact: Media team Email: info@titancapitalmarkets.com Website: https://titancapitalmarkets.com/ SOURCE: TITAN CAPITAL MARKETS The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)

Read More
Posted on

Led by Legend Capital, The Leading Intelligent Special Robot Company AKA Robotics Completes Series A Financing

HONG KONG, Jul 28, 2022 - (ACN Newswire via SEAPRWire.com) - Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as "AKA Robotics"), a leading intelligent special robot company, recently completed its Series A financing round, which was led by Legend Capital. This round of funds will be used to invest in R&D and accelerate its market expansion of the special robotic series products and its overseas market layout, with the mission of "cleaning the world, safe operation".AKA Robotics was established in 2017 and has grown into an enterprise that provides intelligent special robots and comprehensive green solutions for rust removal, cleaning, spraying, polishing, and the inspection of large steel-structure facades. Its robot products have been widely used in ships, petrochemicals, wind power, and other industries.The founding team of AKA Robotics was formed by experts in the field of robotics, coming from Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences. The founder of AKA Robotics is a key technical talent of the Chinese Academy of Sciences, the chief scientist of key R&D projects of the Ministry of Science and Technology, a doctoral supervisor, and a professor-level senior engineer with profound experience in technology R&D and operation management. AKA Robotics has obtained nearly 100 patents and software copyrights in the fields of core technologies, including wall-climbing robots, intelligent control algorithms, controllers, ultrahigh pressure water jet technology, and machine vision.Raymond CHEN, Co-Chief Investment Officer of Legend Capital, said: " Legend Capital continues to pay attention to the investment opportunities in the field of robots. At present, the application of special robots in ships, petrochemicals, wind power, and other industries is facing an inflection point. With the ability to reduce manual work in harsh environments, the robots will play a greater role in industrial production and social life with broad market space. The AKA Robotics team is modest and pragmatic and has been concentrating on polishing products for many years. AKA Robotics has taken the lead in forming large-scale applications in ships and is a leading enterprise in special robots. Legend Capital is very honored to lead this round of financing, and we look forward to AKA Robotics making more breakthroughs in technology, products, and commercialization in the future. At the same time, Legend Capital will continue to support AKA Robotics in growing into a global and platform-based special robot company by providing more proactive value-added services."About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea. It currently manages USD and RMB funds of over US$10 billion in commitments and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service, and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies through solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative. For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital ( https://www.linkedin.com/company/legend-capital ). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Spartan Capital: Society Pass (Nasdaq: SOPA) – Southeast Asia eCommerce Super-App With Billion Dollar Potential

SINGAPORE, Jul 27, 2022 - (ACN Newswire via SEAPRWire.com) - Spartan Capital Securities LLC ("Spartan Capital") issues Equity Research Report on Society Pass Inc. (Nasdaq: SOPA) ("SoPa").Click Here https://bit.ly/3Bmg3l4 (on Society Pass website) or Here https://bit.ly/3vfGzc2 (with Spartan Capital Securities account) to view the full Spartan Capital Equity Research Report.Summary Points:- Society Pass aspires to be the next major Southeast Asia ("SEA") super-app. Comparable success stories such as Lazada, GoTo and Grab have all been accorded multi-billion valuations.- Spartan Capital forecasts SoPa to generate $7.2 million in revenue in 2022, $29.3 million in 2024, up 308% and $59.8 million in 2024, up 104%. Spartan Capital forecasts EBITDA loss narrowing from $10 million in 2022 to just $5.6 million in 2024, then turning positive in 2025.- Spartan Capital likens SoPa to what Masayoshi Son has done with SoftBank, headquartered out of Japan, although with an exclusive focus on e-commerce and SEA.- SoPa operates in five SEA countries (Singapore, Vietnam, Indonesia, Philippines, and Thailand), all are vibrant open economies, recovering from Covid lockdowns and now seeing dynamic growth. SEA consumers are younger and more tech-savvy than counterparts in the US.- SoPa owns 8 portfolio companies in food/beverage (F&B), luxury goods, telecoms, digital media, travel and merchant software sectors and ties them together with its Society Points loyalty program. The eight business units are:-- Leflair - a Vietnam luxury goods flash sale e-commerce company akin to Groupon.-- NusaTrip - an Indonesia travel website company serving the region akin to Expedia.-- Thoughtful Media Group - a Bangkok-based social commerce firm serving US and Asian brands.-- Gorilla Networks - a Singapore blockchain-enabled MVNO serving the mobile/travel markets.-- Mangan - Philippines largest local restaurant food delivery company akin to GrubHub/DoorDash.-- Handycart - a Hanoi, Vietnam restaurant delivery company poised to enter Saigon.-- Pushkart - a Philippines supermarket delivery company akin to Instacart.-- #HOTTAB - a Vietnam restaurant and hotel terminal/back-end software management platform.- Society Points and SoPa's 8 subsidiaries offer multiple ways for consumers to earn loyalty points and to redeem such loyalty points for things of value.- Operating under a matrix management structure, SoPa is led by entrepreneurial Founder, Chairman and CEO, Dennis Nguyen, and a strong team of C-suite executives, business unit CEOs and country managers.- Over half of SoPa's executives are female.About Society PassAs a loyalty and data marketing ecosystem in Singapore, Vietnam, Philippines, and Thailand and with offices located in Singapore, Hanoi, Ho Chi Minh City, Manila, Angeles and Bangkok, SoPa is an acquisition-focused e-commerce holding company operating 7 interconnected verticals (loyalty, merchant software, lifestyle, F&B, telecoms, digital media, and travel), which seamlessly connects millions of consumers and thousands of merchants across multiple product and service categories throughout SEA.SoPa's business model focuses on analysing user data through its Society Pass loyalty platform and circulation of its universal loyalty points or Society Points. The Society Pass loyalty platform drives customer acquisition and retention for merchants. Since its inception, SoPa has amassed over 2.1 million registered consumers and over 6,700 registered merchants/brands onto its platform. It has invested 2+ years building proprietary IT architecture with cutting edge components to effectively scale and support its consumers, merchants, and acquisitions.Society Pass leverages technology to tailor a more personalised experience for customers in the purchase journey and to transform the entire retail value chain in Southeast Asia. SoPa operates #HOTTAB Biz and #HOTTAB POS - a Vietnam-based POS, CRM and analytics technology solutions provider for small and medium-sized enterprises, Leflair.com, Vietnam's leading lifestyle e-commerce platform, Pushkart.ph, a popular grocery delivery company in Philippines, Handycart.vn, a leading online restaurant delivery service based in Vietnam, Gorilla Networks, a Singapore-based, web3-enabled mobile blockchain network operator, Thoughtful Media Group, a Bangkok-based, a social commerce-focused, premium digital video multi-platform network, and Mangan, a leading local restaurant food delivery company in Philippines. For more information, please check out: http://thesocietypass.com/.Media Contacts:PRecious Communicationssopa@preciouscomms.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

The World’s First In-Game NFT Exchange HovR Officially Launched

Pretoria, South Africa, July 21, 2022 – (SEAPRWire) – Vortx Capital Pty LTD, a software investment company with an investment mandate that focuses on actual revenue, zero hype, and real blockchain use cases, has announced the launch of HovR—the world’s first in-gaming NFT exchange for cross-game items and player incentivization. Most of the existing NFT marketplaces require high transaction fees, some ranging from $80 to over $250, to mint an NFT. While a second-layer blockchain serves as a suitable alternative, converting coins is tedious and a technical nightmare for the average user. The problems do not end there. The existence and usage of a second layer blockchain diminish, to a greater level, the composability of the primary blockchain. It also opens up a myriad of security and privacy concerns and removes liquidity. HovR seeks to resolve these sticking points. HovR is built on Qi—one of the most advanced blockchains in the world. Leveraging this network, HovR guarantees remarkably lower fees and an NFT marketplace ideal for real-time use cases. HovR focuses primarily on substantial NFT offerings such as in-game trading collectibles, purchase of web 3.0 domain, safekeeping of wills, ticket touting, social media avatars, and other NFTs with real value. As the possibilities of NFTs in various industries are explored in the form of sports contracts, carbon credits, verifying college degrees, digital passports, medical records, etc., HovR aims to be at the forefront of this revolution, enabling users to exchange one token for another seamlessly. HovR Leverages Qi Blockchain As one of the modern blockchains, HovR will leverage Qi to verify the original owner of the NFT and also ascertain the trading history of each token. Qi blockchain uses an NFT ID system similar to a QR code to make this possible. The Qi blockchain handles as many as 300 times more transactions per second than Bitcoin and ten times more than SWIFT. VortX Capital Pty Ltd was first to market in mining Qi and going forward, the investment company will build and subsequently launch an array of decentralized applications [DApps] and play-to-earn [P2E] games. Talks are currently underway between VortX, the Johannesburg Stock Exchange, and Equity Express Stock Exchange for the software investment company to become the first blockchain-based platform to conduct an IPO in Africa. HovR, as a revolutionary project in the nascent NFT space, aims to offer a secondary market where gamers can comfortably sell off in-game items. HovR also enables renting of these digital assets to other players. As more gamers continue to enter the blockchain-based P2E gaming market, a new market and potential are open for tapping. And HovR positions itself as the perfect platform to lead this new industry, putting players back in the driver’s seat. HovR has launched a collection of unique NFTs comprising the 10,000 largest cities by population. These NFTs will serve as crucial components for a P2E game for world domination. About HOvR NFT Marketplace A product of VortX Capital Pty LTD, HovR is the world’s first in-game NFT exchange for cross-game items. HovR leverages the state-of-the-art Qi blockchain to deliver a secondary marketplace positioned perfectly for the new phase of P2E gaming. Through various groundbreaking features, HovR seeks to put gamers back in the driver’s seat. Social Links: Instagram: https://www.instagram.com/qiblockchain.online/ Twitter: https://twitter.com/qiblockchain Facebook: https://web.facebook.com/QiBlockchain?_rdc=1&_rdr Youtube: https://www.youtube.com/channel/UCxRiEx7ywDyXp3seX8J4DdQ Reddit: https://www.reddit.com/r/qiblockchain/ Reddit: https://www.reddit.com/r/hovrNFT/ Twitter: https://twitter.com/HovrSite Telegram:  https://t.me/HovRonQiblockchain Media Contact Company: HovR Contact: Media Team Email: info@hovr.site Website: https://hovr.site SOURCE: HovR The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)

Read More
Posted on

Legend Capital Portfolio Company: The Global-Leading AI Medical Imaging Company Lunit Goes Public Successfully

HONG KONG, Jul 21, 2022 - (ACN Newswire via SEAPRWire.com) - On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on the KOSDAQ market. Founded in 2013, Lunit successfully established itself as the world's top-notch artificial intelligence technology solution provider, mainly focusing on developing medical software to assist physicians in the realm of tumor diagnosis and treatment. Lunit's flagship products are Lunit INSIGHT and Lunit SCOPE. Lunit INSIGHT is an AI-powered image screening solution, that detects and classifies chest abnormalities and breast cancer. Lunit SCOPE is an AI biomarker for immunotherapy, providing therapy response information that can critically affect treatment outcomes for cancer patients. Legend Capital led Lunit's series B investment round in June 2018 and continued to support Lunit's global business expansion via three additional follow-on investments in 2019 and 2021. For the past 4 years, Lunit not only has produced world-leading AI medical solutions but also gained its commercial value achieving rapid topline growth. Lunit's annual revenue grew by over 460% in 2021 since its initial product commercialization in 2019. As of now, Lunit's image diagnostic products have been certified by 42 countries/regions, including FDA, CE, and KFDA. The company will keep expanding into the global market through cooperation with international giants like GE Healthcare, Fujifilm, and Philips, etc. Legend Capital will continue to assist Lunit in finding untapped business opportunities in China by building up branding and introducing rich portfolio resources for cooperation. Brandon Suh, CEO of Lunit, said: "Lunit's target market for cancer detection and diagnosis is worth 110 billion US dollars (of which the United States accounts for ~USD 45bn and the rest USD 65bn). Lunit's AI medical image analysis technology has significant advantages over traditional technology, and our accurate and efficient solutions have been appreciated by global medical institutions. Lunit's ongoing global expansion can be attributed to the support from our existing partners, Legend Capital has been one of Lunit's key partners in helping us grow our China business by introducing reliable local partners. Legend Capital has been and will continue to be Lunit's strategic global partner going forward." "We like to invest in companies that have a global vision, world-leading technology, and global expansion capabilities. We were very impressed with Lunit's ambition to go global at our initial investment," said Joon-Sung Park, Managing Director of Legend Capital. "With the world's top-notch AI medical imaging technology, Lunit INSIGHT can significantly improve abnormalities detection and early-diagnosis rate, remarkably enhancing the efficiency of cancer diagnosis and treatment. Lunit has built a professional team with technology experts and medical professionals. The six co-founders are all graduates of the Korea Advanced Institute of Science and Technology (KAIST), the nation's first public, research-oriented science and engineering institution. With a commitment to empowering the medical industry by AI technology, Lunit has also hired 12 full-time doctors with an in-depth understanding of medical service. It has provided AI healthcare services to approximately 600 medical institutions in over 40 countries, and has signed an exclusive business contract with Guardant Health, the world's largest liquid biopsy diagnostic company, to collaborate on cancer drug development." At present, "Lunit INSIGHT CXR Triage" and "Lunit INSIGHT MMG" have been certified by the U.S. Food and Drug Administration (FDA) by the end of 2021, and Lunit will continue to expand the global market by obtaining Medical Device Single Audit Program (MDSAP) certification in the US, Canada, Japan, Australia and Brazil, etc. Legend Capital has invested heavily in companies that integrate technology and the medical industry and has kept betting on AI medical sectors. In addition to Lunit, Legend Capital has also invested in AI medical companies such as Xbiome, an AI microbiome drug development company; StoneWise, an AI drug R&D platform; Deepwise, an AI medical imaging company; BioMap, a biocomputing platform; Deep Informatics ++, an AI medical pathology diagnosis company; and Unimed, an AI brain diagnosis and treatment platform.About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea. It currently manages USD and RMB funds of over US$10 billion in commitments and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies through solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative. For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital ( https://www.linkedin.com/company/legend-capital ). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

G Mining Ventures 宣布为 Tocantinzinho 黄金项目提供 4.81 亿美元的融资方案

BROSSARD, QC, Jul 19, 2022 - (亚太商讯 via SEAPRWire.com) - G Mining Ventures Corp. （“GMIN”或“公司”）高兴地宣布，该公司已就一项总额为 4.81 亿美元的综合建设融资方案达成具有约束力的承诺，用于开发和建设其 100% 拥有的 Tocantinzinho Gold 项目（“TZ”或“项目”）。 该项目仍有望在 2024 年下半年实现投产。尽管市场环境动荡，但仍能按时获得融资，这是对管理团队的有力支持，以及该项目的技术和经济优势。图 1 – 资金来源和用途总结图 2 – 探索营地扩建图 3 – Moraes Almeida 的货运代理基地图 4 – 通道升级图 5 – Itaituba 教育总监 Severino 先生与 Louis-Pierre Gignac融资方案亮点 - 4.81 亿美元- 通过与战略投资者（“战略投资者”）以每股普通股0.80 加元的价格进行私募融资 1.16 亿美元-- La Mancha Investments S.à r.l. （“La Mancha”） 投资 6880 万美元-- Franco-Nevada Corporation（“Franco-Nevada”）投资 2750 万美元-- Eldorado Gold Corporation（“Eldorado Gold”）投资 2000 万美元- 与 Franco-Nevada 公司合作的2.5 亿美元黄金流-- 代表Franco-Nevada公司最大的黄金流之一，位于主要金矿- 来自 Franco-Nevada 的 7500 万美元高级担保定期贷款- 与 Caterpillar Financial Services Limited（“Cat Financial”）进行 4000 万美元的设备融资- 黄金流和定期贷款融资已结束，其余融资方案预计将在 Q3-22 结束GMIN 总裁兼首席执行官 Louis-Pierre Gignac 评价道：“我们很高兴欢迎两个新的基石合作伙伴 Franco-Nevada 和 La Mancha，他们致力于 GMIN 的长期成功和发展。 他们的承诺以及 Eldorado Gold 的持续支持进一步验证了管理团队以及自 2021 年收购项目以来为推进该项目所做的工作。在我们今年早些时候发布的积极可行性研究的基础上，这一融资方案标志着进展的下一步 GMIN 并允许我们继续在 TZ 释放价值。 TZ 的即将发展为我们不断增长的利益相关者群体带来价值，包括在帕拉州创造有吸引力的就业机会和经济繁荣。”Franco-Nevada 总裁兼首席执行官 Paul Brink 评论说：“我们很高兴为 GMIN 提供这一建设融资方案。Tocantinzinho 是一个有吸引力的项目，位于一个多产的地区，位于一个良好的司法管辖区。GMIN 团队有一个跟踪 - 成为业内最有能力的矿山建设团队之一。伴随我们流投资的债务和股权投资反映了我们对 GMIN 团队能力和项目潜力的信心。La Mancha Capital Advisory LLP 的执行合伙人 Karim Nasr 评论说：“La Mancha 集团在采矿业的成功投资方面有着悠久的记录，我们希望通过 La Mancha 对 GMIN 的投资进一步巩固这一记录。 我们对管理团队的独特技能以及 TZ 的质量和潜力印象深刻。 我们期待成为 GMIN 通过 TZ 的发展成为中间生产商之旅的一部分，并且随着公司评估这个初始项目之外的未来增长机会。”项目融资概况正如 2022 年第一季度发布的可行性研究中详述的那样，初始项目资本成本估计为 4.27 亿美元，其中包括 3800 万美元的应急费用（税前 10%）。考虑到 4900 万美元的应付税款后，所需资金总额为 4.76 亿美元。 GMIN 有资格获得 1800 万美元的可收回税款和税收抵免，在计算所需的开发资本时未扣除，因为这只会在生产开始后收到。截至 2022 年 6 月 30 日，GMIN 已发生资本支出 2100 万美元，剩余估计资本成本为 4.55 亿美元，即 4.17 亿美元，不包括 3800 万美元的应急费用。迄今为止，总计 7100 万美元的采购正在跟踪预算，主要集中在加工厂和采矿设备的主要设备上。 GMIN 的采购战略进展顺利，该战略侧重于在采购设备和供应品时最大限度地利用巴西资源。总融资方案 4.81 亿美元，加上截至 2022 年 6 月 30 日的手头现金 5400 万美元，总可用资本为 5.35 亿美元，并为 GMIN 提供超过剩余估计资本余额的承诺资本来源。据估计，Cat Financial 提供的设备融资中的 3200 万美元将在施工期间使用，其中 800 万美元作为储备金。在考虑企业成本、营运资金和偿债后，GMIN 估计现金和预算应急费用总计 8100 万美元（18%），详情如下。图 1 – 资金来源和用途总结https://www.acnnewswire.com/topimg/Low_GMining202207181ch.jpg融资方案摘要就融资方案而言，GMIN 和 Franco-Nevada 已就以下事项签署了最终文件：(i) 一项最终的买卖协议，根据该协议，Franco-Nevada (Barbados) Corporation 将向 GMIN 支付 2.5 亿美元的押金，以获得一定比例 TZ 应付黄金产量，(ii) Franco-Nevada 通过其全资子公司之一提供本金为 7500 万美元的高级担保定期贷款，以及 (iii) Franco-Nevada 购买 以私募方式发行约 4470 万股 GMIN 普通股，认购价为每股 0.80 加元，总收益为 2750 万美元（3580 万加元）。同时，GMIN、La Mancha 和 Eldorado Gold 已就 La Mancha 和 Eldorado Gold 以私募方式分别购买 1.119 亿股和 3250 万股 GMIN 普通股签署最终文件，认购价为每股 0.80 加元，总收益分别为 68.8 美元和 2000 万美元（89.5 加元和 2600 万加元）。股权私募——战略投资者- 1.513 亿加元（1.164 亿美元）的股权融资，定价为每股 0.80 加元，通过非经纪私募配售- La Mancha 已同意认购 GMIN 的 111,879,265 股普通股，总收益为 8950 万加元（6880 万美元）-- La Mancha 将在收盘时认购 82,875,000 股普通股以持有 GMIN 已发行普通股的19.8%，并在获得 GMIN 无利害关系的股东批准后再认购 29,004,265 股普通股以持有 25.0%-- GMIN 和 La Mancha 将签订一份投资者权利协议，授予 La Mancha 提名两名董事进入 GMIN 董事会的权利，只要 La Mancha 保持至少 15% 的所有权-- La Mancha Capital Advisory LLP 的执行合伙人 Karim Nasr 将在第一期的截止日期被提名，第二位董事将在稍后日期跟进-- La Mancha 将被授予惯常的反稀释权、注册权和信息权，并已同意 24 个月的停顿期，其中包括对处置的限制- Franco-Nevada 已同意认购 GMIN 的 44,687,500 股普通股，总收益为 3580 万加元（2750 万美元）-- Franco-Nevada 将持有 GMIN 9.9% 的已发行普通股-- GMIN 和 Franco-Nevada 签订了一份投资者权利协议，该协议授予 Franco-Nevada 对 GMIN 未来任何特许权使用费和流式销售的优先购买权，只要 Franco-Nevada 保持 GMIN 已发行普通股5.0% 的最低所有权-- Franco-Nevada 也被授予习惯性的反稀释权，并同意 24 个月的停顿期，其中包括对处置的限制- Eldorado Gold 已大幅行使其反稀释权，并同意认购 GMIN 的 32,500,000 股普通股，总收益为 2,600 万加元（2,000 万美元）-- Eldorado Gold 将持有 GMIN 17.7% 的已发行普通股Gignac 家族的成员以及 GMIN 董事和高级管理人员（统称“内部人员”）持有 34,722,869 股普通股，占 GMIN 交易前已发行普通股的 7.8%。为了进一步与战略投资者保持一致，内部人士已同意对任何 GMIN 证券的销售或转让进行 24 个月的限制。私募须经多伦多证券交易所创业板（“TSXV”）接受，并将分两批完成，第一批将于 2022 年 7 月结束。第二批将包括向拉曼查发行约2,900 万股 GMIN 普通股的收益约为 2,320 万加元（1,780 万美元），根据 TSXV 的政策，这将取决于无利害关系的 GMIN 股东的多数批准，预计将在22年第三季度完成。在撰写本文时，已与战略投资者和内部人士签订了超过 45% 的无利害关系 GMIN 股东的投票支持协议。黄金流 – Franco-Nevada- 押金：2.5亿美元- 交割：TZ 黄金产量的12.5%，交割 300,000 盎司后降至 7.5%- 持续付款：交割时现货黄金价格的 20%- ESG 倡议：每年最多 250,000 美元，为期四年，用于投资于 TZ 周边社区的环境倡议和社会项目- 提取存款须满足此类交易的某些惯常条件定期贷款– Franco-Nevada- 融资金额：7500 万美元- 期限：6.0年- 可用期：在完全提取流存款后，GMIN 可自行决定提供长达3.5 年的多次提取工具-- 每年1.0% 未提取金额的备用费，GMIN 可以选择在前 2 年期间累积和资本化- 票券：3个月定期担保隔夜融资利率加上每年5.75%的保证金，项目完成前，完成后保证金降至4.75%-- 2年的利息递延期，在此期间GMIN可以选择应计和资本化利息- 摊销：本金、应计利息和应计费用自 2025 年 12 月起按如下方式偿还：-- 10 次相等的季度付款，相当于未偿余额的7.5%； 和-- 本金在到期日一次性付清等于25.0%- 原始发行折扣：适用于提取金额的2.0%- Franco-Nevada 将获得 1150 万份认股权证，期限为 5 年，行使价为每股1.90 加元-- 行使价等于作为 GMIN 2021 年 9 月融资的一部分而发行的现有 3,750 万份认股权证的行使价，这是目前唯一未发行的认股权证-- 认股权证将具有无现金行使机制，以使 Franco-Nevada 在行使时避免其持有的 GMIN 已发行普通股超过9.9%设备融资- 通过与 Cat Financial 签订的经信贷批准的条款清单提供高达 4000 万美元的设备融资，用于供应 Caterpillar 主要和辅助采矿机队以及工程机械- 在完成最终文件之前，根据 GMIN 董事会的最终建设决定和其他惯例条件，Cat Financial 租赁融资将提供给公司Tocantinzinho发展更新自 2022 年 5 月 26 日发布最新项目更新以来，GMIN 已推进项目的以下方面：采购- 迄今为止的采购总额为 7100 万美元，正在跟踪预算，主要集中在加工厂和采矿设备的主要设备上-- 采购的设备含有大量巴西成分- 已执行长交货期设备采购订单，以完成建设进度，以实现2024年下半年投产- 设备交付将随着时间的推移而错开，第一台机器将于 2022 年 9 月交付到现场- 初级采矿设备目前使用手头现金提供资金，但将通过上述 4000 万美元的设备融资方案进行再融资电源供应输电线路和 Novo Progresso 变电站的详细工程已完成建设 - 早期工程活动- 勘探营地容量已增加到 350 个床位，并增加了 10 个宿舍-- 新水井、餐厅和厨房设备投入使用- 临时爆炸物储存设施正在建设中，护堤到位，围栏即将完成- Moraes Almeida的物流基地即将完工-- 交付后，该设施将由物流货运代理管理，这将允许合并货物以交付到现场- 随着旱季的到来，通道升级仍在继续图 2 – 探索营地扩建https://www.acnnewswire.com/topimg/Low_GMining202207182.jpg图 3 – Moraes Almeida 的货运代理基地https://www.acnnewswire.com/topimg/Low_GMining202207183.jpg图 4 – 通道升级https://www.acnnewswire.com/topimg/Low_GMining202207184.jpgTocantinzinho 对当地社区的好处当地就业- 该项目预计在建设阶段创造多达1,200个工作岗位，在运营阶段创造超过600个永久性工作岗位- 至少 30% 的员工将从 Itaituba、Morais Almeida、Jardim de Ouro 和 Mamoal 当地社区雇用- 除了施工阶段的培训，GMIN 计划投入超过 85,000 小时进行内部培训，以培养当地劳动力的技能社区计划- GMIN 为 Moraes Almeida 当地中小学 Escola Municipal de Ensino Fundamental César Almeida 提供互联网接入和 IT 基础设施-- 学校在校生1700人，教职工80人- GMIN 将通过提供资金和专业知识来支持当地社区对教育、健康和文化倡议的要求- Franco-Nevada 每年提供高达 250,000 美元，为期四年，用于投资 TZ 周边社区的环境倡议和社会项目图 5 – Itaituba 教育总监 Severino 先生与 Louis-Pierre Gignachttps://www.acnnewswire.com/topimg/Low_GMining202207185.jpg当地其他长期受益- 创建持久的共享基础设施，例如 190 公里的输电线路-- 除了通过 80% 的可再生能源为该项目供电外，输电线路还将成为国家公用事业基础设施的一部分，为该地区提供可靠的电力- 在 Jardim do Ouro 建造一条旁路，通过将其他公司（以及未来 GMIN 运营）当前工业活动的繁忙交通转移到远离村庄的地方来提高安全性- GMIN 将优先考虑本地采购，以促进能力建设和业务发展顾问：BMO Capital Markets 就 La Mancha 战略投资担任 GMIN 的独家财务顾问。 Stikeman Elliott LLP、Blake, Cassels & Graydon LLP、Grebler Advogados 和 Mattos Filho Advogados 担任 GMIN 的法律顾问。时间表和后续步骤获得融资方案后，公司将专注于以下活动：- 积极的建设决策；- 22年第三季度 完成万米勘探钻探计划并取得成果；- 通过 H1-23 完成详细工程； 和- 预计 H2-24 将首次生产黄金，2025 年第一年全面投产。可行性研究 3D VRIFY 演示要查看该研究的 3D VRIFY 演示文稿，请单击以下链接：可行性研究 3D VRIFY 演示文稿，或访问公司网站 www.gminingventures.com。Tocantinzinho 融资方案电话会议详情GMIN will host a conference call to discuss the financing package.日期: 2022年7月18日周一时间: 东部时间上午10:30参与者可以通过以下方式加入电话会议：拨打北美免费电话：+1-888-506-0062国际：973.528.0011访问代码：564993网络直播 URL: https://www.webcaster4.com/Webcast/Page/2892/46159对于那些无法参加的人，电话会议的基于网络的存档将在 2023 年 7 月 18 日星期二之前通过上述相同的网络广播 URL 播放。 此外，将从下午 1:30 开始提供音频重播。 东部时间从 2022 年 7 月 18 日星期一到 2022 年 8 月 1 日星期一。要观看重播，请致电 1.877.481.4010（美国和加拿大）或 1.919.882.2331（国际）并输入确认码 46159 #。其他信息有关 GMIN 的更多信息，请访问网站 www.gminingventures.com 或联系：Jessie Liu-Ernsting投资者关系与沟通总监647.728.4176info@gminingventures.com关于 G Mining Ventures Corp.G Mining Ventures Corp. (TSXV: GMIN) (OTCQX: GMINF) 是一家矿产勘探公司，从事贵金属项目的收购、勘探和开发，以利用成功的矿山开发带来的价值提升。 GMIN 凭借强大的资本渠道和成熟的开发专业知识，已准备好成长为下一个中端贵金属生产商。 GMIN 目前由其旗舰 Tocantinzinho 项目锚定，该项目位于巴西对采矿友好且具有前景的帕拉州。关于Franco-NevadaFranco-Nevada 是领先的专注于黄金的特许权使用费和流媒体公司，拥有最大、最多元化的现金流资产组合。其商业模式为投资者提供黄金价格和勘探选择权，同时限制成本通胀风险。 Franco-Nevada 没有债务，并利用其自由现金流来扩大其投资组合并支付股息。它在多伦多和纽约证券交易所的交易代码为 FNV。 Franco-Nevada 是行之有效的黄金投资。关于 La Mancha 和 La Mancha Fund SCSpLa Mancha 是 La Mancha Fund SCSp（“基金”）的全资子公司，这是一家总部位于卢森堡的投资基金，由 La Mancha Capital Advisory LLP 提供建议，专注于贵金属和能源转型领域的投资。 La Mancha 的总部位于 31-33 Avenue Pasteur L-2311 Luxembourg。 La Mancha 将根据适用的加拿大证券法提交一份预警报告，该报告将在 SEDAR 网站 www.sedar.com 上的 GMIN 资料中提供，也可通过以下规定联系 Karim-Michel Nasr 获得。关于 La Mancha Capital Advisory LLPLa Mancha Capital Advisory LLP 就对具有全球视野的公开上市和私人勘探、特许权使用费和矿业公司的战略投资向基金提供建议。 La Mancha Capital Advisory LLP 是一家具有长远眼光的投资顾问，其任务是通过提供长期股权资本以及运营和董事会层面的专业知识来支持矿业公司实现持续增长，以进一步推动投资组合公司的业绩和扩张。La Mancha Capital Advisory LLP 是 G10 Capital Limited 的指定代表，该公司由金融行为监管局 (FRN 648953) 授权和监管。其他信息有关 La Mancha Capital Advisory LLP 的更多信息，请访问网站 www.lamanchacapitaladvisory.com 或联系：Karim-Michel Nasr管理合伙人兼联合首席信息官+44.203.960.2020contact@lamancha.com关于 La Mancha 的订阅2022 年 7 月 18 日，La Mancha 与 GMIN 签订了认购协议（“认购协议”），据此，La Mancha 同意通过以下方式认购 GMIN 股本中的 111,879,265 股普通股（“普通股”） 以每股普通股 0.80 加元的价格进行非公开配售，总现金对价为 89,503,412 加元（“认购”）。在满足或豁免所有成交条件的情况下，认购事项将分两批完成：(i) 在 2022 年 7 月 29 日或之前，La Mancha 将以每股普通股 0.80 加元的总现金认购 82,875,000 股普通股 对价 66,300,000 加元（“初始认购”）； (ii) 至迟于 2022 年 11 月 30 日，La Mancha 将以每股普通股 0.80 加元的购买价格认购 29,004,265 股普通股，总现金对价为 23,203,412 加元（“后续认购”）。La Mancha 目前不拥有或控制或指导任何普通股。完成首次认购后，La Mancha 将实益拥有并控制和控制合共 82,875,000 股普通股，占当时 GMIN 已发行和流通普通股的约 19.8%。后续认购事项完成后，La Mancha 将实益拥有合共 111,879,265 股普通股，占当时已发行和流通普通股的约 25%，并拥有控制权和指挥权。在初始认购结束时，La Mancha 和 GMIN 将签订一份投资者权利协议，根据该协议，La Mancha 将获得某些董事提名、反稀释和注册权。 La Mancha 将于认购事项完成时收购的普通股将用于投资目的。未来，拉曼查可能会不时通过市场交易、私人安排、国债发行或其他方式增加或减少对GMIN的投资。关于Eldorado黄金Eldorado 是一家黄金和基本金属生产商，在土耳其、加拿大、希腊和罗马尼亚拥有采矿、开发和勘探业务。公司拥有高技能和敬业的员工队伍、安全和负责任的运营、高质量资产组合以及与当地社区的长期合作伙伴关系。 Eldorado 的普通股在多伦多证券交易所 (TSX: ELD) 和纽约证券交易所 (NYSE: EGO) 交易。Eldorado Gold 目前拥有 46,926,372 股 GMIN 普通股，约占已发行 GMIN 普通股的 18.2%。在完成上述 Eldorado Gold 购买 32,500,000 股 GMIN 普通股后，Eldorado Gold 将拥有 79,426,372 股 GMIN 普通股，占第一批交易结束时已发行 GMIN 普通股的 19.0%，在本期交易结束时拥有 17.7%第二批。Eldorado Gold 建议将购买这些证券用于投资目的。 Eldorado Gold 可能会根据市场和其他条件，增加或减少其对 GMIN 证券的实益所有权，无论是在公开市场上、通过私下协商的协议或其他方式，但受多种因素影响，包括一般市场条件和其他可用投资和商机。本披露是根据多边文书 62-104 提供的，该文书还要求提交一份预警报告，其中包含与上述事项有关的额外信息。预警报告的副本将在 SEDAR 上的 GMIN 发行人资料（www.sedar.com）下提供，并可应 Eldorado Gold 的要求通过以下联系信息联系 Eldorado Gold 获得。联系信息:Eldorado Gold Corporation1188 - 550 Burrard Street Bentall 5Vancouver, British ColumbiaV6C 2B5Tel: 604.601.6656Lisa Wilkinson投资者关系副总裁604.757 2237 or 1.888.353.8166lisa.wilkinson@eldoradogold.comTSX Venture Exchange 及其监管服务提供商（该术语在 TSX Venture Exchange 的政策中定义）均不对本新闻稿的充分性或准确性承担责任。前瞻性信息的警示性声明除历史事实陈述外，本新闻稿中包含的所有陈述构成某些证券法含义内的“前瞻性信息”和“前瞻性陈述”，并基于截至本新闻稿发布之日的预期和预测 发布。 本新闻稿中包含的前瞻性陈述包括但不限于：A. 与项目融资相关的，例如： (i) 在22年第三季度完成融资方案； (ii) 满足所有条件以实现提款并收到 Franco-Nevada 黄金流下的5 亿美元存款； (iii) 无利害关系的 GMIN 股东批准第二批 La Mancha 股权配售； (iv) TSXV 的私募接受； (v) Franco-Nevada 黄金流下的黄金交付量； (vi) 根据 Franco-Nevada 协议完成 ESG 举措； 和 (vii) Cat Financial 租赁融资的结束；B. 与项目本身相关的，例如： (i) 经董事会批准，于22年第三季度全面开工； (ii) 2024年下半年实现生产； (iii) 按时交付设备并优先考虑当地采购； (iv) 某些早期工程活动接近完成； (v) 在建设期间和运营阶段创造就业机会，特别是通过当地社区的就业； (vi) 通过培训计划发展当地劳动力技能； (vii) 响应当地社区有关教育、健康和文化倡议的要求； (viii) 创建持久的基础设施； 和 (ix) 在22年第三季度完成钻井计划，并在 H1-23 完成详细工程；C. 而且，更一般地说，总裁兼首席执行官的上述评论以及 Franco-Nevada 首席执行官和 La Mancha Capital Advisory LLP 的管理合伙人的评论，以及上述标题为“时间表和后续步骤”和“ 关于 G Mining Ventures Corp.”。前瞻性陈述基于截至本新闻稿发布时的预期、估计和预测。 前瞻性陈述必然基于一些估计和假设，虽然公司在此类陈述时认为这些估计和假设是合理的，但本质上会受到重大业务、经济和竞争不确定性和或有事件的影响。 这些估计和假设可能被证明是不正确的。 此类假设包括但不限于 1.30 美元：加元汇率，以及上述“时间表和后续步骤”和“关于 G Mining Ventures Corp.”部分所列项目的基础。其中许多不确定性和或有可能直接或间接影响并可能导致实际结果与任何前瞻性陈述中明示或暗示的结果大不相同。无法保证，特别是但不限于，公司将 (i) 关闭其项目融资的所有组成部分，如本新闻稿所述，(ii) 在 2022 年或任何时候就该项目做出积极的建设决定，(iii ) 将项目投入商业生产或 (iv) 成为中间黄金生产商，因为未来事件可能与公司目前的预期大不相同。就其本质而言，前瞻性陈述涉及一般和特定的固有风险和不确定性，并且存在无法实现估计、预测、预测和其他前瞻性陈述或假设不能反映未来经验的风险。提供前瞻性陈述的目的是提供有关管理层对未来的预期和计划的信息。提醒读者不要过分依赖这些前瞻性陈述，因为许多重要的风险因素和未来事件可能导致实际结果与所表达的信念、计划、目标、期望、预期、估计、假设和意图存在重大差异在此类前瞻性陈述中。本新闻稿中的所有前瞻性陈述均受这些警示性陈述的限制，以及该公司向加拿大证券监管机构提交的其他文件中的陈述，包括但不限于公司相关章节中的警示性陈述(i) 日期为 2022 年 6 月 3 日的年度信息表，截至 2021 年 12 月 31 日的财政年度，以及 (ii) 管理层讨论与分析。公司告诫说，上述可能影响未来结果的因素清单并非详尽无遗，并且可能会不时出现新的、不可预见的风险。除非适用法律要求，否则公司不承担任何更新或修改任何前瞻性陈述或解释后续实际事件与此类前瞻性陈述之间任何重大差异的意图或义务。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

Read More
Posted on

G Mining Ventures 宣布为 Tocantinzinho 黄金项目提供 4.81 亿美元的融资方案

加拿大布洛萨德(QC), 2022年7月18日 – G Mining Ventures Corp. （“GMIN”或“公司”）高兴地宣布，该公司已就一项总额为 4.81 亿美元的综合建设融资方案达成具有约束力的承诺，用于开发和建设其 100% 拥有的 Tocantinzinho Gold 项目（“TZ”或“项目”）。 该项目仍有望在 2024 年下半年实现投产。尽管市场环境动荡，但仍能按时获得融资，这是对管理团队的有力支持，以及该项目的技术和经济优势。融资方案亮点 - 4.81 亿美元通过与战略投资者（“战略投资者”）以每股普通股0.80 加元的价格进行私募融资 1.16 亿美元La Mancha Investments S.à r.l. （“La Mancha”） 投资 6880 万美元Franco-Nevada Corporation（“Franco-Nevada”）投资 2750 万美元Eldorado Gold Corporation（“Eldorado Gold”）投资 2000 万美元与 Franco-Nevada 公司合作的2.5 亿美元黄金流代表Franco-Nevada公司最大的黄金流之一，位于主要金矿来自 Franco-Nevada 的 7500 万美元高级担保定期贷款与 Caterpillar Financial Services Limited（“Cat Financial”）进行 4000 万美元的设备融资黄金流和定期贷款融资已结束，其余融资方案预计将在 Q3-22 结束GMIN 总裁兼首席执行官 Louis-Pierre Gignac 评价道：“我们很高兴欢迎两个新的基石合作伙伴 Franco-Nevada 和 La Mancha，他们致力于 GMIN 的长期成功和发展。 他们的承诺以及 Eldorado Gold 的持续支持进一步验证了管理团队以及自 2021 年收购项目以来为推进该项目所做的工作。在我们今年早些时候发布的积极可行性研究的基础上，这一融资方案标志着进展的下一步 GMIN 并允许我们继续在 TZ 释放价值。 TZ 的即将发展为我们不断增长的利益相关者群体带来价值，包括在帕拉州创造有吸引力的就业机会和经济繁荣。”Franco-Nevada 总裁兼首席执行官 Paul Brink 评论说：“我们很高兴为 GMIN 提供这一建设融资方案。Tocantinzinho 是一个有吸引力的项目，位于一个多产的地区，位于一个良好的司法管辖区。GMIN 团队有一个跟踪 - 成为业内最有能力的矿山建设团队之一。伴随我们流投资的债务和股权投资反映了我们对 GMIN 团队能力和项目潜力的信心。La Mancha Capital Advisory LLP 的执行合伙人 Karim Nasr 评论说：“La Mancha 集团在采矿业的成功投资方面有着悠久的记录，我们希望通过 La Mancha 对 GMIN 的投资进一步巩固这一记录。 我们对管理团队的独特技能以及 TZ 的质量和潜力印象深刻。 我们期待成为 GMIN 通过 TZ 的发展成为中间生产商之旅的一部分，并且随着公司评估这个初始项目之外的未来增长机会。”项目融资概况正如 2022 年第一季度发布的可行性研究中详述的那样，初始项目资本成本估计为 4.27 亿美元，其中包括 3800 万美元的应急费用（税前 10%）。考虑到 4900 万美元的应付税款后，所需资金总额为 4.76 亿美元。 GMIN 有资格获得 1800 万美元的可收回税款和税收抵免，在计算所需的开发资本时未扣除，因为这只会在生产开始后收到。截至 2022 年 6 月 30 日，GMIN 已发生资本支出 2100 万美元，剩余估计资本成本为 4.55 亿美元，即 4.17 亿美元，不包括 3800 万美元的应急费用。迄今为止，总计 7100 万美元的采购正在跟踪预算，主要集中在加工厂和采矿设备的主要设备上。 GMIN 的采购战略进展顺利，该战略侧重于在采购设备和供应品时最大限度地利用巴西资源。总融资方案 4.81 亿美元，加上截至 2022 年 6 月 30 日的手头现金 5400 万美元，总可用资本为 5.35 亿美元，并为 GMIN 提供超过剩余估计资本余额的承诺资本来源。据估计，Cat Financial 提供的设备融资中的 3200 万美元将在施工期间使用，其中 800 万美元作为储备金。在考虑企业成本、营运资金和偿债后，GMIN 估计现金和预算应急费用总计 8100 万美元（18%），详情如下。图 1 – 资金来源和用途总结融资方案摘要就融资方案而言，GMIN 和 Franco-Nevada 已就以下事项签署了最终文件：(i) 一项最终的买卖协议，根据该协议，Franco-Nevada (Barbados) Corporation 将向 GMIN 支付 2.5 亿美元的押金，以获得一定比例 TZ 应付黄金产量，(ii) Franco-Nevada 通过其全资子公司之一提供本金为 7500 万美元的高级担保定期贷款，以及 (iii) Franco-Nevada 购买 以私募方式发行约 4470 万股 GMIN 普通股，认购价为每股 0.80 加元，总收益为 2750 万美元（3580 万加元）。同时，GMIN、La Mancha 和 Eldorado Gold 已就 La Mancha 和 Eldorado Gold 以私募方式分别购买 1.119 亿股和 3250 万股 GMIN 普通股签署最终文件，认购价为每股 0.80 加元，总收益分别为 68.8 美元和 2000 万美元（89.5 加元和 2600 万加元）。股权私募——战略投资者1.513 亿加元（1.164 亿美元）的股权融资，定价为每股 0.80 加元，通过非经纪私募配售La Mancha 已同意认购 GMIN 的 111,879,265 股普通股，总收益为 8950 万加元（6880 万美元）La Mancha 将在收盘时认购 82,875,000 股普通股以持有 GMIN 已发行普通股的19.8%，并在获得 GMIN 无利害关系的股东批准后再认购 29,004,265 股普通股以持有 25.0%GMIN 和 La Mancha 将签订一份投资者权利协议，授予 La Mancha 提名两名董事进入 GMIN 董事会的权利，只要 La Mancha 保持至少 15% 的所有权La Mancha Capital Advisory LLP 的执行合伙人 Karim Nasr 将在第一期的截止日期被提名，第二位董事将在稍后日期跟进La Mancha 将被授予惯常的反稀释权、注册权和信息权，并已同意 24 个月的停顿期，其中包括对处置的限制Franco-Nevada 已同意认购 GMIN 的 44,687,500 股普通股，总收益为 3580 万加元（2750 万美元）Franco-Nevada 将持有 GMIN 9.9% 的已发行普通股GMIN 和 Franco-Nevada 签订了一份投资者权利协议，该协议授予 Franco-Nevada 对 GMIN 未来任何特许权使用费和流式销售的优先购买权，只要 Franco-Nevada 保持 GMIN 已发行普通股5.0% 的最低所有权Franco-Nevada 也被授予习惯性的反稀释权，并同意 24 个月的停顿期，其中包括对处置的限制Eldorado Gold 已大幅行使其反稀释权，并同意认购 GMIN 的 32,500,000 股普通股，总收益为 2,600 万加元（2,000 万美元）Eldorado Gold 将持有 GMIN 17.7% 的已发行普通股Gignac 家族的成员以及 GMIN 董事和高级管理人员（统称“内部人员”）持有 34,722,869 股普通股，占 GMIN 交易前已发行普通股的 7.8%。为了进一步与战略投资者保持一致，内部人士已同意对任何 GMIN 证券的销售或转让进行 24 个月的限制。私募须经多伦多证券交易所创业板（“TSXV”）接受，并将分两批完成，第一批将于 2022 年 7 月结束。第二批将包括向拉曼查发行约2,900 万股 GMIN 普通股的收益约为 2,320 万加元（1,780 万美元），根据 TSXV 的政策，这将取决于无利害关系的 GMIN 股东的多数批准，预计将在22年第三季度完成。在撰写本文时，已与战略投资者和内部人士签订了超过 45% 的无利害关系 GMIN 股东的投票支持协议。黄金流 – Franco-Nevada押金：2.5亿美元交割：TZ 黄金产量的12.5%，交割 300,000 盎司后降至 7.5%持续付款：交割时现货黄金价格的 20%ESG 倡议：每年最多 250,000 美元，为期四年，用于投资于 TZ 周边社区的环境倡议和社会项目提取存款须满足此类交易的某些惯常条件定期贷款– Franco-Nevada融资金额：7500 万美元期限：6.0年可用期：在完全提取流存款后，GMIN 可自行决定提供长达3.5 年的多次提取工具每年1.0% 未提取金额的备用费，GMIN 可以选择在前 2 年期间累积和资本化票券：3个月定期担保隔夜融资利率加上每年5.75%的保证金，项目完成前，完成后保证金降至4.75%2年的利息递延期，在此期间GMIN可以选择应计和资本化利息摊销：本金、应计利息和应计费用自 2025 年 12 月起按如下方式偿还：10 次相等的季度付款，相当于未偿余额的7.5%； 和本金在到期日一次性付清等于25.0%原始发行折扣：适用于提取金额的2.0%Franco-Nevada 将获得 1150 万份认股权证，期限为 5 年，行使价为每股1.90 加元行使价等于作为 GMIN 2021 年 9 月融资的一部分而发行的现有 3,750 万份认股权证的行使价，这是目前唯一未发行的认股权证认股权证将具有无现金行使机制，以使 Franco-Nevada 在行使时避免其持有的 GMIN 已发行普通股超过9.9%设备融资通过与 Cat Financial 签订的经信贷批准的条款清单提供高达 4000 万美元的设备融资，用于供应 Caterpillar 主要和辅助采矿机队以及工程机械在完成最终文件之前，根据 GMIN 董事会的最终建设决定和其他惯例条件，Cat Financial 租赁融资将提供给公司Tocantinzinho发展更新自 2022 年 5 月 26 日发布最新项目更新以来，GMIN 已推进项目的以下方面：采购迄今为止的采购总额为 7100 万美元，正在跟踪预算，主要集中在加工厂和采矿设备的主要设备上采购的设备含有大量巴西成分已执行长交货期设备采购订单，以完成建设进度，以实现2024年下半年投产设备交付将随着时间的推移而错开，第一台机器将于 2022 年 9 月交付到现场初级采矿设备目前使用手头现金提供资金，但将通过上述 4000 万美元的设备融资方案进行再融资电源供应输电线路和 Novo Progresso 变电站的详细工程已完成建设 - 早期工程活动勘探营地容量已增加到 350 个床位，并增加了 10 个宿舍新水井、餐厅和厨房设备投入使用临时爆炸物储存设施正在建设中，护堤到位，围栏即将完成Moraes Almeida的物流基地即将完工交付后，该设施将由物流货运代理管理，这将允许合并货物以交付到现场随着旱季的到来，通道升级仍在继续图 2 – 探索营地扩建图 3 – Moraes Almeida 的货运代理基地图 4 – 通道升级Tocantinzinho 对当地社区的好处当地就业该项目预计在建设阶段创造多达1,200个工作岗位，在运营阶段创造超过600个永久性工作岗位至少 30% 的员工将从 Itaituba、Morais Almeida、Jardim de Ouro 和 Mamoal 当地社区雇用除了施工阶段的培训，GMIN 计划投入超过 85,000 小时进行内部培训，以培养当地劳动力的技能社区计划GMIN 为 Moraes Almeida 当地中小学 Escola Municipal de Ensino Fundamental César Almeida 提供互联网接入和 IT 基础设施学校在校生1700人，教职工80人GMIN 将通过提供资金和专业知识来支持当地社区对教育、健康和文化倡议的要求Franco-Nevada 每年提供高达 250,000 美元，为期四年，用于投资 TZ 周边社区的环境倡议和社会项目图 5 – Itaituba 教育总监 Severino 先生与 Louis-Pierre Gignac当地其他长期受益创建持久的共享基础设施，例如 190 公里的输电线路除了通过 80% 的可再生能源为该项目供电外，输电线路还将成为国家公用事业基础设施的一部分，为该地区提供可靠的电力在 Jardim do Ouro 建造一条旁路，通过将其他公司（以及未来 GMIN 运营）当前工业活动的繁忙交通转移到远离村庄的地方来提高安全性GMIN 将优先考虑本地采购，以促进能力建设和业务发展顾问：BMO Capital Markets 就 La Mancha 战略投资担任 GMIN 的独家财务顾问。 Stikeman Elliott LLP、Blake, Cassels & Graydon LLP、Grebler Advogados 和 Mattos Filho Advogados 担任 GMIN 的法律顾问。时间表和后续步骤获得融资方案后，公司将专注于以下活动：积极的建设决策；22年第三季度 完成万米勘探钻探计划并取得成果；通过 H1-23 完成详细工程； 和预计 H2-24 将首次生产黄金，2025 年第一年全面投产。可行性研究 3D VRIFY 演示要查看该研究的 3D VRIFY 演示文稿，请单击以下链接：可行性研究 3D VRIFY 演示文稿，或访问公司网站 www.gminingventures.com。Tocantinzinho 融资方案电话会议详情GMIN will host a conference call to discuss the financing package.日期: 2022年7月18日周一时间: 东部时间上午10:30参与者可以通过以下方式加入电话会议：拨打北美免费电话：+1-888-506-0062国际：973.528.0011访问代码：564993网络直播 URL: https://www.webcaster4.com/Webcast/Page/2892/46159对于那些无法参加的人，电话会议的基于网络的存档将在 2023 年 7 月 18 日星期二之前通过上述相同的网络广播 URL 播放。 此外，将从下午 1:30 开始提供音频重播。 东部时间从 2022 年 7 月 18 日星期一到 2022 年 8 月 1 日星期一。要观看重播，请致电 1.877.481.4010（美国和加拿大）或 1.919.882.2331（国际）并输入确认码 46159 #。其他信息有关 GMIN 的更多信息，请访问网站 www.gminingventures.com 或联系：Jessie Liu-Ernsting投资者关系与沟通总监647.728.4176info@gminingventures.com关于 G Mining Ventures Corp.G Mining Ventures Corp. (TSXV: GMIN) (OTCQX: GMINF) 是一家矿产勘探公司，从事贵金属项目的收购、勘探和开发，以利用成功的矿山开发带来的价值提升。 GMIN 凭借强大的资本渠道和成熟的开发专业知识，已准备好成长为下一个中端贵金属生产商。 GMIN 目前由其旗舰 Tocantinzinho 项目锚定，该项目位于巴西对采矿友好且具有前景的帕拉州。关于Franco-NevadaFranco-Nevada 是领先的专注于黄金的特许权使用费和流媒体公司，拥有最大、最多元化的现金流资产组合。其商业模式为投资者提供黄金价格和勘探选择权，同时限制成本通胀风险。 Franco-Nevada 没有债务，并利用其自由现金流来扩大其投资组合并支付股息。它在多伦多和纽约证券交易所的交易代码为 FNV。 Franco-Nevada 是行之有效的黄金投资。关于 La Mancha 和 La Mancha Fund SCSpLa Mancha 是 La Mancha Fund SCSp（“基金”）的全资子公司，这是一家总部位于卢森堡的投资基金，由 La Mancha Capital Advisory LLP 提供建议，专注于贵金属和能源转型领域的投资。 La Mancha 的总部位于 31-33 Avenue Pasteur L-2311 Luxembourg。 La Mancha 将根据适用的加拿大证券法提交一份预警报告，该报告将在 SEDAR 网站 www.sedar.com 上的 GMIN 资料中提供，也可通过以下规定联系 Karim-Michel Nasr 获得。关于 La Mancha Capital Advisory LLPLa Mancha Capital Advisory LLP 就对具有全球视野的公开上市和私人勘探、特许权使用费和矿业公司的战略投资向基金提供建议。 La Mancha Capital Advisory LLP 是一家具有长远眼光的投资顾问，其任务是通过提供长期股权资本以及运营和董事会层面的专业知识来支持矿业公司实现持续增长，以进一步推动投资组合公司的业绩和扩张。La Mancha Capital Advisory LLP 是 G10 Capital Limited 的指定代表，该公司由金融行为监管局 (FRN 648953) 授权和监管。其他信息有关 La Mancha Capital Advisory LLP 的更多信息，请访问网站 www.lamanchacapitaladvisory.com 或联系：Karim-Michel Nasr管理合伙人兼联合首席信息官+44.203.960.2020contact@lamancha.com关于 La Mancha 的订阅2022 年 7 月 18 日，La Mancha 与 GMIN 签订了认购协议（“认购协议”），据此，La Mancha 同意通过以下方式认购 GMIN 股本中的 111,879,265 股普通股（“普通股”） 以每股普通股 0.80 加元的价格进行非公开配售，总现金对价为 89,503,412 加元（“认购”）。在满足或豁免所有成交条件的情况下，认购事项将分两批完成：(i) 在 2022 年 7 月 29 日或之前，La Mancha 将以每股普通股 0.80 加元的总现金认购 82,875,000 股普通股 对价 66,300,000 加元（“初始认购”）； (ii) 至迟于 2022 年 11 月 30 日，La Mancha 将以每股普通股 0.80 加元的购买价格认购 29,004,265 股普通股，总现金对价为 23,203,412 加元（“后续认购”）。La Mancha 目前不拥有或控制或指导任何普通股。完成首次认购后，La Mancha 将实益拥有并控制和控制合共 82,875,000 股普通股，占当时 GMIN 已发行和流通普通股的约 19.8%。后续认购事项完成后，La Mancha 将实益拥有合共 111,879,265 股普通股，占当时已发行和流通普通股的约 25%，并拥有控制权和指挥权。在初始认购结束时，La Mancha 和 GMIN 将签订一份投资者权利协议，根据该协议，La Mancha 将获得某些董事提名、反稀释和注册权。 La Mancha 将于认购事项完成时收购的普通股将用于投资目的。未来，拉曼查可能会不时通过市场交易、私人安排、国债发行或其他方式增加或减少对GMIN的投资。关于Eldorado黄金Eldorado 是一家黄金和基本金属生产商，在土耳其、加拿大、希腊和罗马尼亚拥有采矿、开发和勘探业务。公司拥有高技能和敬业的员工队伍、安全和负责任的运营、高质量资产组合以及与当地社区的长期合作伙伴关系。 Eldorado 的普通股在多伦多证券交易所 (TSX: ELD) 和纽约证券交易所 (NYSE: EGO) 交易。Eldorado Gold 目前拥有 46,926,372 股 GMIN 普通股，约占已发行 GMIN 普通股的 18.2%。在完成上述 Eldorado Gold 购买 32,500,000 股 GMIN 普通股后，Eldorado Gold 将拥有 79,426,372 股 GMIN 普通股，占第一批交易结束时已发行 GMIN 普通股的 19.0%，在本期交易结束时拥有 17.7%第二批。Eldorado Gold 建议将购买这些证券用于投资目的。 Eldorado Gold 可能会根据市场和其他条件，增加或减少其对 GMIN 证券的实益所有权，无论是在公开市场上、通过私下协商的协议或其他方式，但受多种因素影响，包括一般市场条件和其他可用投资和商机。本披露是根据多边文书 62-104 提供的，该文书还要求提交一份预警报告，其中包含与上述事项有关的额外信息。预警报告的副本将在 SEDAR 上的 GMIN 发行人资料（www.sedar.com）下提供，并可应 Eldorado Gold 的要求通过以下联系信息联系 Eldorado Gold 获得。联系信息:Eldorado Gold Corporation1188 - 550 Burrard Street Bentall 5Vancouver, British ColumbiaV6C 2B5Tel: 604.601.6656Lisa Wilkinson投资者关系副总裁604.757 2237 or 1.888.353.8166lisa.wilkinson@eldoradogold.comTSX Venture Exchange 及其监管服务提供商（该术语在 TSX Venture Exchange 的政策中定义）均不对本新闻稿的充分性或准确性承担责任。前瞻性信息的警示性声明除历史事实陈述外，本新闻稿中包含的所有陈述构成某些证券法含义内的“前瞻性信息”和“前瞻性陈述”，并基于截至本新闻稿发布之日的预期和预测 发布。 本新闻稿中包含的前瞻性陈述包括但不限于：A. 与项目融资相关的，例如： (i) 在22年第三季度完成融资方案； (ii) 满足所有条件以实现提款并收到 Franco-Nevada 黄金流下的5 亿美元存款； (iii) 无利害关系的 GMIN 股东批准第二批 La Mancha 股权配售； (iv) TSXV 的私募接受； (v) Franco-Nevada 黄金流下的黄金交付量； (vi) 根据 Franco-Nevada 协议完成 ESG 举措； 和 (vii) Cat Financial 租赁融资的结束； B. 与项目本身相关的，例如： (i) 经董事会批准，于22年第三季度全面开工； (ii) 2024年下半年实现生产； (iii) 按时交付设备并优先考虑当地采购； (iv) 某些早期工程活动接近完成； (v) 在建设期间和运营阶段创造就业机会，特别是通过当地社区的就业； (vi) 通过培训计划发展当地劳动力技能； (vii) 响应当地社区有关教育、健康和文化倡议的要求； (viii) 创建持久的基础设施； 和 (ix) 在22年第三季度完成钻井计划，并在 H1-23 完成详细工程；C. 而且，更一般地说，总裁兼首席执行官的上述评论以及 Franco-Nevada 首席执行官和 La Mancha Capital Advisory LLP 的管理合伙人的评论，以及上述标题为“时间表和后续步骤”和“ 关于 G Mining Ventures Corp.”。前瞻性陈述基于截至本新闻稿发布时的预期、估计和预测。 前瞻性陈述必然基于一些估计和假设，虽然公司在此类陈述时认为这些估计和假设是合理的，但本质上会受到重大业务、经济和竞争不确定性和或有事件的影响。 这些估计和假设可能被证明是不正确的。 此类假设包括但不限于 1.30 美元：加元汇率，以及上述“时间表和后续步骤”和“关于 G Mining Ventures Corp.”部分所列项目的基础。其中许多不确定性和或有可能直接或间接影响并可能导致实际结果与任何前瞻性陈述中明示或暗示的结果大不相同。无法保证，特别是但不限于，公司将 (i) 关闭其项目融资的所有组成部分，如本新闻稿所述，(ii) 在 2022 年或任何时候就该项目做出积极的建设决定，(iii ) 将项目投入商业生产或 (iv) 成为中间黄金生产商，因为未来事件可能与公司目前的预期大不相同。就其本质而言，前瞻性陈述涉及一般和特定的固有风险和不确定性，并且存在无法实现估计、预测、预测和其他前瞻性陈述或假设不能反映未来经验的风险。提供前瞻性陈述的目的是提供有关管理层对未来的预期和计划的信息。提醒读者不要过分依赖这些前瞻性陈述，因为许多重要的风险因素和未来事件可能导致实际结果与所表达的信念、计划、目标、期望、预期、估计、假设和意图存在重大差异在此类前瞻性陈述中。本新闻稿中的所有前瞻性陈述均受这些警示性陈述的限制，以及该公司向加拿大证券监管机构提交的其他文件中的陈述，包括但不限于公司相关章节中的警示性陈述(i) 日期为 2022 年 6 月 3 日的年度信息表，截至 2021 年 12 月 31 日的财政年度，以及 (ii) 管理层讨论与分析。公司告诫说，上述可能影响未来结果的因素清单并非详尽无遗，并且可能会不时出现新的、不可预见的风险。除非适用法律要求，否则公司不承担任何更新或修改任何前瞻性陈述或解释后续实际事件与此类前瞻性陈述之间任何重大差异的意图或义务。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

Read More
Posted on

Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB

HONG KONG, Jul 7, 2022 - (ACN Newswire via SEAPRWire.com) - Jiangsu Huili Biotechnology Co., Ltd ("Huili Bio"), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB. This financing round was co-led by Legend Capital and the fresh capital will be used to accelerate the construction and operation of large-scale production facilities, the R&D of new product pipelines and the expansion of the talent team.Founded in 2018, Huili Bio is dedicated to the computational design of enzyme components at the core of synthetic biological reactions. With cutting-edge achievements, Huili Bio is one of the few bio-manufacturing companies with comprehensive capabilities in core technology, mass production on a large scale and closed-loop commercialization. It provides solutions in multiple fields such as pharmaceutical intermediates, animal protection and food. In addition to an R&D center in Tianjin, Huili Bio has also established a production base in Taizhou City, Jiangsu Province, which is under the expansion of flexible production line. Huili Bio's enzyme computational design platform is the first computational platform in China to realize the full-scenario design of enzymes. This platform enables the company to transform products in the pharmaceutical field, so as to achieve high efficiency from laboratory development, industrial production to commercialization, reducing costs by nearly 30% and increasing yields by almost 70% compared to traditional chemical methods, and also helps Huili Bio deploy more than 10 innovative products in various fields.Commenting on the financing, Henry JI, Executive Director of Legend Capital, said: "The synthetic biomaterials market is vast and an important area in the green and low-carbon direction. As the core component of synthetic biology, the design and transformation of enzymes will benefit more traditional biotechnology industries with low-cost and sustainable green production methods. Legend Capital has long focused on investment in the 'IT+' industry, and Huili Bio is a model of combining information technology and biotechnology (IT+BT). With a background in combining industry and research, Huili Bio is a company with differentiated product selection and multi-pipeline extension capabilities. The company has mastered the industry's leading enzyme computing design technology and has rapidly achieved the scale production of high-value-added products such as pharmaceutical intermediates through the layout of the whole industry chain and has been fully recognized by the industry's head customers. Legend Capital is glad to join hands with Huili Biotech to contribute to China's biological 'intelligence'."As an intersection of information science, life science and material science, synthetic biology and bio-based materials have been the focus of Legend Capital's carbon-neutral technology investments. Under the background of carbon peaking and carbon neutrality, Legend Capital's investments focus on energy decarbonization, vehicle electrification/intelligence, synthetic biology, etc. Energy decarbonization includes photovoltaic, wind power and smart grid; vehicle electrification/intelligence includes lithium battery vehicles, hydrogen fuel cell vehicles, battery recycling and others. Legend Capital has made investments in the field of synthetic biology by investing in outstanding companies such as Huili Bio, Zhongke Guosheng, and Tidetron Bio.About Legend CapitalFounded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, South Korea. It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors. Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative. For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital ( https://www.linkedin.com/company/legend-capital ). Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Elite Partners Acquires Distribution Facility in UK

LONDON, Jul 6, 2022 - (ACN Newswire via SEAPRWire.com) - Elite Partners Capital ("EPC") has completed another acquisition of a distribution facility in the UK for over GBP 30M. The asset is located within Wrexham Industrial Estate, a premier industrial location and one of the largest industrial estates in the UK, well placed to serve both Wales and England. The estate extends to over 550 hectares and is home to over 340 businesses creating employment for over 10,000 people. The distribution facility, consisting of two detached industrial warehouse facilities, provides in total 723,114 sqft of built up space on a 45.9 acres land. It is fully let to one of the UK's largest shop-at-home retailers Shop Direct Home Shopping (a subsidiary of The Very Group - a multi-brand online retailer and financial services provider in the UK and Ireland). This represents the first UK acquisition for the second series of EPC's Logistic Funds. Riding on its strong track record and the deep network the manager has built over the years, Elite Logistics Fund II continues to focus on building a portfolio of high-quality logistics warehouse or infrastructure across Europe and the UK. The acquisition in Wrexham, according to Mr. Victor Song, CEO of Elite Partners Capital, is part of the firm's bigger plan to amass an institutional-scale portfolio of prime logistics assets across Europe and the UK. He added, "We believe that this asset is particularly well-placed to benefit from the highly dynamic logistics market in the UK where the demand for logistics warehouses remains strong and resilient". The UK Industrial & Logistics sector has seen an outperformance due to the e-Commerce boom over the years, which was further accelerated by the Covid-19 pandemic. For this transaction, Colliers acted for Elite Partners Capital and B8 Real Estate acted for the vendor. About Elite Partners CapitalIncorporated in 2017, Elite Partners Capital is a Singapore-based licensed fund manager. The Elite Logistics Fund series has a Pan-European strategy focusing on prime logistics assets in the high-growth and defensive sectors.Media Contact:enquiries@elitepartnerscapital.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More